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Intracellular trafficking is essential for proper maturation and functioning of eukaryotic 
cells. The terminal stage of trafficking is the membrane fusion of two distinct compartments 
leading to the mixing of contents. In order to regulate this process organelles are enriched with 
specific fusion proteins termed SNAREs. While the core fusion machinery is well understood, 
relatively little is known about the role lipid regulation plays in membrane fusion. It has been 
well established that enrichment of specific regulatory lipids leads to recruitment and activation 
of the fusion machinery. Additionally these lipids are modified by specific kinases, phosphatases 
and lipases allowing regulation of the different stages of fusion. Furthermore, some regulatory 
lipids have been found to enhance the fission process. Taken together, it becomes evident that 
the dynamic lipid remodeling of membranes plays a key role in both membrane fusion and 
fission.  
In order to study in vitro membrane fusion with a system containing endogenous 
proteins and lipid, the vacuole from Saccharomyces cerevisiae is utilized. Yeast vacuoles 
undergo homotypic vacuolar fusion which is utilized to maintain homeostasis and occurs during 
inheritance. During the fusion pathway, vacuoles accumulate the glycerophospholipid 
phosphatidylinositol 3-phosphate (PI3P).  PI3P is a positive regulatory of fusion that functions 
through the recruitment of multiple components of the vacuolar fusion machinery including the 
soluble SNARE Vam7.  
Vam7 interacts with PI3P through its PX domain and utilizes this interaction for proper 




allosterically regulated by the Vam7 Mid-domain (MD). I identified a polybasic region in the MD 
and found that mutating these basic residues to alanine, generating Vam7-6A, led to impaired 
vacuolar fusion. This was due to decreased association with its cognate SNAREs as well as the 
HOPS tethering complex. The reduced protein binding by Vam7-6A was not due to reduced 
anionic lipid binding as initially hypothesized but was associated with enhanced PI3P binding 
through Vam7’s PX domain. I now posit that binding PI3P with higher affinity allosterically 
inhibits binding to partner proteins. It can therefore be concluded that PI3P enrichment is 
necessary to initially trigger the fusion process through recruitment of fusion factors, but either 
the turnover of PI3P or the release of fusion proteins from PI3P is necessary for fusion to 
proceed.   
While enrichment of lipids can lead to organelle specific regulation, there are lipid 
regulation mechanisms shared throughout the cell. Of specific interest is the lipid phosphatidic 
acid (PA) and diacylglycerol (DAG) which are interconverted by the PA phosphatase Pah1 and 
the DAG kinase Dgk1. Previous work showed DAG acts as a positive regulator of vacuolar fusion 
and is proposed to reduce the force requirements of vacuolar fusion. I hypothesized that 
deletion of Dgk1 would lead to enhanced levels of DAG leading to enhanced fusion. In Chapter 
3 I show that deletion of Dgk1 causes a significant enhancement in fusion and leads to a 
reduction in the force requirements for membrane fusion. However addition of DAG alone was 
unable to fully reproduce the Dgk1 deletion phenotype suggesting a reduction in PA was in part 




In addition to PI3P, the vacuole is also highly enriched in phosphatidylinositol 3,5-
bisphosphate (PI(3,5)P2), a lipid shown to trigger vacuole fission. In Chapter 4 I show PI(3,5)P2 
acts as a novel inhibitor of Ca2+ efflux during vacuolar fusion. I hypothesized that this inhibitory 
activity was through regulation of the Ca2+ efflux channel Yvc1. Surprisingly our study showed 
PI(3,5)P2 acts  through activation of the Ca
2+ influx channel Pmc1 rather than inhibition of Yvc1. 
This is in direct opposition to PI(3,5)P2’s role as an activator of Yvc1 in membrane fission.  Taken 
together these findings demonstrate the complex nature of membrane fusion regulation by 
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CHAPTER 1: INTRODUCTION 
Eukaryotic cells utilize organelle specific enrichment of lipids as a means of regulation.  
Classically, lipid dependent regulation is understood simply as recruitment of specific proteins 
to various membranes, however a large body of work has now shown that lipids contribute to a 
wide array or regulation including: transcriptional regulation 1, protein sequestering 2–4, 
microdomain formation5,6 modulation of biophysical properties 7,8, and modulation of protein 
activity9–11. Regulatory lipids include the sphingolipids, sterols, and the glycerophospholipids 
which contain the phosphatidylinositols. Further regulation is enabled by the rapid 
interconversion of lipids by various lipases, kinases, and phosphatases allowing spatiotemporal 
control of cellular events. In order to understand the mechanism by which lipids regulate 
cellular function some researchers have utilized the endolysosomal pathway in saccharomyces 
cerevisiae and in particular have dissected the lipid dependent mechanism of vacuolar 
membrane fusion.  Yeast vacuolar membrane fusion serves as an ideal model system to study 
lipid regulation owing to the fact that the core membrane fusion machinery is highly conserved 
in higher eukaryotes. Furthermore the regulation of fusion by lipids is conserved in analogous 
stystems through Eurkarya. In this chapter I seek to highlight the current understanding of lipid 
regulation in vacuolar membrane fusion.  
The Role of PI3P in Endosomal Maturation and Recruitment of the Vacuolar Fusion Machinery 
The endosomal pathway in yeast is in part characterized by enrichment of the lipid 
phosphatidylinositol(PI) 3-phosphate (PI3P) 12–15. The class III PI 3-kinase Vps34 in complex with 




for protein sorting to the vacuole16,17. Subcellular fractionation studies identified endosomes as 
the specific enrichment site of Vps34 however the mechanism by which Vps34 is recruited to 
the endosome is still undetermined18. Previous work has shown that the phosphatidic acid 
phosphatase Pah1 is required for the recruitment of Vps34 to vacuoles, which is necessary for 
organelle maturation. However, the mechanism by which this occurs remains unclear 19. 
Additionally Slessareva et al. demonstrated that activation of Vps34 is dependent on Gpa1, the 
alpha subunit of the pheromone sensing heterotrimeric G protein complex. PI3P is utilized to 
recruit multiple endosomal factors to the endosomal membrane such as the tethering factor 
EEA1 in mammalian cells, the Rab GTPase in Vps21 in yeast, ESCRT-0, and ESCRT-II 20–24, 
however it also plays a role in the maturation of the early endosome to the late endosome and 
eventually the vacuole.  
Generation of PI3P by Vps34 acts as an initiator of endosomal maturation through 
recruitment of Mon1-Ccz1, the heterodimeric guanine exchange factor for the late endosomal 
Rab Ypt7.  This occurs through direct binding interactions between PI3P and Mon1-Ccz1. The 
association of Mon1 with PI3P has been shown through liposome binding studies as well as 
indirectly via competition assays and PI3P depletion 25,26. The Mon1-PI3P binding interaction 
appears to be through the C-terminal domain of Mon1. PI3P induced conformational changes 
are crucial to proper Mon1-Ccz1 function as replacement of the C-terminal domain with the 
PI3P binding FYVE domain restored Mon1 localization but did not rescue vacuolar morphology 
defects 11. Localization of Mon1-Ccz1 to the early endosome leads to further maturation 
through recruitment of endosomal factors and eventually recruitment and activation of the late 




enrichment of the membrane with various effectors such as the retromer, homotypic fusion 
and vacuolar protein-sorting (HOPS) complex, and Ivy1 27–29. Full vacuolar maturation concludes 
via activation of Ypt7, by the GEF activity of Mon1-Ccz1, causing inactivation and displacement 
of the early endosomal Rab GTPase Vps2130. 
In addition to Rab GTPase exchange, the exchange of tethering factors is also critical to 
proper vacuole maturation. The early endosomal tethering complex CORVET is exchanged for 
the late endosomal/vacuolar complex HOPS. These tethering complexes are heterohexameric, 
containing a conserved core of 4 subunits as well as two organelle specific subunits. This 
exchange of HOPS for CORVET occurs primarily through the interactions between the HOPS 
specific subunits, Vps39 and Vps41, with Ypt7 and Mon1-Ccz1 28,31–33. Studies have shown that 
direct binding of HOPS to PI3P may also play a role in this exchange process 34. The role of direct 
binding to PI3P in recruitment of HOPS may only play a small role however as the same study 
found HOPS was also binds PI4P, PI(4,5)P2 and PI(3,5)P2. Finally HOPS is also maintained on the 
membrane through interactions with the Phox homology (PX) domain of the soluble SNARE 
Vam7 through multiple interacts to Vam7’s PX domain 34 
PI3P not only recruits the vacuolar tethering machinery, Ypt7 and the HOPS complex, 
but is also utilized for recruitment of the soluble Qc SNARE Vam7. Vam7 is composed of 3 
distinct domains, a PX domain, the conserved SNARE domain, and an alpha helical middle 
domain 35–38. Vam7 is unique among SNARES as it associates with the vacuole transiently via 
binding of PI3P through its N-terminal lipid binding PX domain rather than with a proteinaceous 




the membrane through insertion of a hydrophobic helix into the bilayer 39. Intriguingly we 
found that the middle domain plays a role in regulating the PX domain’s ability to interact with 
PI3P. 
Compared to the PX and SNARE domains of Vam7, the middle domain has been 
relatively ignored. Preliminary work assumed the middle domain merely served as a linker 
between the PX and SNARE domains; however we showed that this alpha-helical domain 
contains a poly-basic region (PBR) which plays a role in Vam7’s ability to promote fusion and 
augments its membrane association40. Removal of this PBR by mutation of the 6 basic residues 
to alanine causes decreased association with both the HOPS complex and cognate SNARES 
leading to impaired ability to promote membrane fusion. This lack of association was not due to 
reduced association with PI3P as first hypothesized but rather tighter association of Vam7 with 
PI3P through its PX domain. We conclude now that PI3P binding is initially required for 
recruitment and association of the fusion machinery while following stages of fusion require 
turnover of PI3P or release of Vam7 through allosteric regulation.  
A Role for PI(3,5)P2 as a Switch Between Membrane Fusion and Fission 
Phosphatidylinositol 3,5-bisphosphate (PI3,5P2), in contrast to PI3P,  is not found 
throughout the endosome pathway but rather predominately in the late endosome and 
vacuole. PI(3,5)P2 is made exclusively by the PI3P 5-kinase Fab1, which was shown to be 
localized to the vacuole and pre-vacuolar compartments through subcellular fractionation and 
immunofluorescence studies 41,42.  Deletion of Fab1 results in a complete loss of PI(3,5)P2 as 




PI(3,5)P2 5-phosphatase Fig4. Surprisingly, it was found that loss of Fig4 leads to an overall 
decrease in PI(3,5)P2 levels 
43–45. It was later identified that Fig4 and Fab1 associate in complex, 
and loss of Fig4 alters Fab1 activity. In addition to Fig4, Fab1 complexes with Vac7, Vac14, and 
Atg18 46–48.  
While the role of PI3P has been extensively examined in the context of vacuolar 
membrane fusion, the effects of PI(3,5)P2 have not been well characterized. Previous work has 
however established that PI(3,5)P2 plays a key role in membrane fission regulation. Others have 
shown that hypertonic conditions lead to a rapid increase in PI(3,5)P2 levels  
44,49,50. This rise in 
PI(3,5)P2  triggers a release of Ca
2+ through the vacuolar Ca2+ exporter Yvc1 9. Deletion of either 
Fab1 or Yvc1 attenuates the ability of hypertonic conditions to cause membrane fission. This 
indicates the increase in PI(3,5)P2 and subsequent release of Ca
2+ are essential for membrane 
fission.  
PI(3,5)P2 also acts as a regulator of vacuolar acidification. Direct binding of the vacuole 
specific V-ATPase V0 subunit, Vph1, to PI(3,5)P2 is required for proper V-ATPase assembly 
10. The 
concept of organelle specific phosphoinositides regulating V-ATPase activity was further 
reinforced by elucidating the regulation of the plasma membrane specific homolog of Vph1, 
Stv1, by PI4P 51. Vacuolar acidification has also been shown to be an essential component of 
membrane fission as inhibition of V-ATPase H+ pumping activity leads to fission defects 52. In 
addition to its canonical function of acidifying the vacuole, the V-ATPase has also been 




V-ATPase by PI(3,5)P2 in terms of H
+ transport, it’s possible that PI(3,5)P2 may also regulate V-
ATPase stimulated membrane fusion.  
The V-ATPase V0 complex has been shown to play a role in vacuolar fusion through the 
formation of V0-V0 interactions 
53. Work by the Mayer group established that the V0 complex 
acts in a late stage of fusion following trans-SNARE pairing. V0 fusogenic activity is distinct from 
its canonical H+ pump activity as removal of the V1 subunit or treatment with H
+ pumping 
inhibitors permit fusion. Additional work identified the V0 complex as a regulator of Ca
2+ efflux 
as shown by a lack of Ca2+ efflux upon treatment with antibody against Vph1 55.  Deletion of 
Vph1 did not abolish fusion associated Ca2+ efflux, therefore it appears Vph1 does not directly 
cause Ca2+ but rather acts to regulate a Ca2+ channel. Our work has shown inactivation of the 
vacuolar Ca2+ ATPase Pmc1, which depletes the cytosol of Ca2+ through importing into the 
vacuole lumen, is required to facilitate Ca2+ efflux (Miner unpublished), therefore we propose 
that Vph1 acts to inactivate Pmc1 upon localization to the fusion machinery. Vph1 enrichment 
appears to acts as a regulation point in the fusion pathway that triggers Ca2+ allowing the 
formation of V0 trans-complexes
53. In support of this mechanism, a physical interaction 
between Vph1 and Pmc1 has been observed though follow-up work would be necessary to 
further elucidate the role of this interaction 56. 
An unanswered question is what role PI(3,5)P2 may play in the fusion pathway. We 
hypothesis that in addition to enabling membrane fission through activation of the ion 
transport activities of the V-ATPase and Yvc1, that PI(3,5)P2 also inhibits fusion through 




interactions have been shown to inhibit fusion 54 suggesting V0 functions as either a H
+ 
transporter through V0-V1 complex formation or fusogenically while not in complex. Taken 
together with the identification of PI(3,5)P2 as a promoter of the V0-V1 complex we propose 
that PI3,5P2 acts to inhibit fusion through conformation changes to V0 that prohibits the 
formation of V0 trans-complexes. Our work has also shown that PI(3,5)P2 acts to enhance Pmc1 
activity (miner unpublished), therefore we additionally propose that stabilization of the V0-V1 
complex destabilizes the interactions of Vph1 for Pmc1 causing Pmc1 to remain active.  
Additional regulatory lipids 
In addition to the phosphatidylinositol 3-phosphates, several regulatory lipids have been 
identified for vacuolar fusion including phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), 
diacylglycerol (DAG), phosphatidic acid (PA), phosphatidylethanolamine (PE), and Ergosterol 57–
60. Early work showed that PI(4,5)P2 is a necessary lipid for fusion and appeared to act in both 
priming and a late stage of fusion 57. Specifically treatment with antibodies against PI(4,5)P2 
leads to severe fusion inhibition which can be rescued by addition of exogenous PI(4,5)P2. 
Additionally binding of PI(4,5)P2 with Enth domain or depletion with the bacterial phosphatase 
SigD also blocked fusion 5,61.  The exact mechanism by which PI(4,5)P2 acts in fusion has not 
been fully determined, however a role for PI(4,5)P2 has been established in actin regulation 
(Higgs and Pollard 2000; Karunakaran et al. 2012.; Rozelle et al. 2000). Actin remodeling has 
been identified as necessary for both vertex ring enrichment 65 and vacuole fusion 66.  
Fully elucidating the requirement of PI(4,5)P2 in vacuolar fusion is complicated by the 





identified DAG as a regulator of vacuolar fusion. Production of DAG through PLC activity was 
found to be a requirement for the early stage of fusion, though independent, while DAG was 
additionally required at a late stage of fusion.  It is hypothesized that increased levels of DAG 
reduce the force requirement for bilayer mixing, thus promoting membrane fusion 8. In support 
of this it was found that elevating DAG levels leads to enhanced fusion 67. Vacuoles lacking 
Dgk1, which converts DAG to PA, showed a 40% enhancement in fusion as well as the ability to 
support  fusion with Vam7Q283R, a mutant which reduces the ability of the SNARE bundle to 
generate force. Exogenous long acyl chain DAG was also capable of promoting fusion, however 
short acyl chain DAG was ineffective reinforcing the concept that the biophysical properties of 
the lipid acyl chains are required for fusion stimulation. 
While increased levels of DAG have been shown to enhance vacuole fusion, it should be 
noted that deletion of Dgk1 appears to also cause a reduction in levels of PA on the vacuole. PA 
was shown to be essential for vacuole fusion through proteoliposome studies 58, as well as 
acting as a negative regulator of priming 2. The stimulatory role of PA in fusion occurs through 
the recruitment of the SNARE chaperone Sec18 as well as the HOPS complex 58, whereas 
elevated levels of PA can lead to improper vacuole maturation as shown in Pah1 deletion 
strains 19. Sec18 PA dependent recruitment appears to be through direct binding; however 
Sec18 activity is inhibited by elevated levels of PA 2. It is hypothesized therefore that PA levels 
are elevated to enrich the vacuolar membrane with Sec18, followed by subsequent loss of PA 
by Pah1 and activation of Sec18. Inhibition of Sec18 activity by PA has also been observed on ER 
derived microsomes suggesting this is a conserved membrane fusion mechanism rather than 




machinery are ubiquitous throughout the cell rather than localized to specific organelles as the 
phosphoinositides are. 
Two additional lipids, PE and ergosterol, have been identified as playing a role in the 
priming stage of vacuole fusion 58,60. Mima et al. identified that in addition to PA, PE is also a 
necessary lipid for proteoliposome based fusion. While not much is known at this point about 
the mechanism of PE fusion regulation, it was identified that PE facilitated the assembly of 
SNARES. PE does not appear to affect membrane association of SNARE chaperones, suggesting 
it may only play a role in the regulation of their activity. Ergosterol has also been identified as 
being required during the priming stage of fusion. Specifically ligands which bind to ergosterol 
inhibited the release of the Sec18 adaptor protein Sec1760,68. Ergosterol is known to affect 
protein mobility 69 and therefore it is proposed that a lack of ergosterol may inhibit SNARE 
dissociation and halt Sec18 activity. In addition to its role in priming, ergosterol is predicted to 
be necessary for enrichment of the fusion vertex ring through stabilization of microdomains. A 
similar phenomenon has been established for SNAREs in the presence of cholesterol 70. 
Inhibition of ergosterol with the binding ligand Filipin led to reduced vertex ring enrichment of 
Ypt7, Vam3, Vam7, and PI3P further supporting this concept 5. Finally both PE and ergosterol, in 
addition to DAG, have been identified as enhancers of membrane fusion due to their formation 
of non-bilayer structures 8. 
Conclusion 
Vacuolar membrane fusion is a highly concerted and regulated cellular event that is 




roles in modulating the biophysical characteristics of the membrane leading to enhanced 
membrane mixing and microdomain formation. The acidic lipid PA appears to play the role of 
gatekeeper, preventing fusion until its conversion to DAG by Pah1 signals priming to begin. The 
phosphoinositides in particular play a crucial role as signaling molecules.  Recruitment and 
activation of Mon1-Ccz1 by PI3P initiates vacuolar maturation via Rab GTPase exchange and 
controls the entire fusion cascade 71.  Finally it appears that PI(3,5)P2  generation by Fab1 may 
serve as a molecular switch that alters the vacuolar machinery from fusion to fission.  It is clear 
that lipids perform a diverse array of essential regulatory roles in cellular functions and the 
continual discovery of new mechanism suggests it will remain a rich field of study. 
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CHAPTER 2: The Central Polybasic Region of the Soluble SNARE (Soluble N-Ethylmaleimide-
sensitive Factor Attachment Protein Receptor) Vam7 Affects Binding to Phosphatidylinositol 
3-Phosphate by the PX (Phox Homology) Domain 
ABSTRACT 
The yeast vacuole requires four SNAREs to trigger membrane fusion including the 
soluble Qc-SNARE Vam7. The N-terminal PX domain of Vam7 binds to the lipid 
phosphatidylinositol 3-phosphate (PI3P) and the tethering complex HOPS, while the C-terminal 
SNARE motif forms SNARE complexes. Vam7 also contains an uncharacterized middle domain 
that is predicted to be a coiled-coil domain with multiple helices. One helix contains a polybasic 
region (PBR) comprised of R164, R168, K172, K175, R179, and K186. Polybasic regions are often 
associated with non-specific binding to acidic phospholipids including phosphoinositides. 
Although the PX domain alone binds PI3P we theorized that the Vam7 PBR could bind to 
additional acidic phospholipids enriched at fusion sites. Mutating each of the basic residues in 
the PBR to an alanine (Vam7-6A) led to attenuated vacuole fusion. The defective fusion of 
Vam7-6A was due in part to inefficient association with its cognate SNAREs and HOPS, yet the 
overall vacuole association of Vam7-6A was similar to wild type. Experiments testing the 
binding of Vam7 to specific signaling lipids showed that mutating the PBR to Alanines 
augmented binding to PI3P. The increased binding to PI3P by Vam7-6A likely contributed to the 
observed wild type levels of vacuole association while protein-protein interactions were 




Vam7-6A to make Vam7-7A. Thus the Vam7 PBR affects PI3P binding by the PX domain and in 
turn affects binding to SNAREs and HOPS to support efficient fusion.   
______________________________________ 
This chapter appeared in its entirety in the Journal of Biological Chemistry and is referred to in this 
dissertation as “Miner et al. 2016”. Miner, G.E. et al. 2016. “The Central Polybasic Region of the Soluble 
Snare (Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein Receptor) Vam7 Affects Binding to 
Phosphatidylinositol 3-Phosphate by the PX (Phox Homology) Domain.” Journal of Biological Chemistry 




The study of membrane lipid composition is vital to gaining a complete understanding of 
membrane trafficking and fusion. Membranes can contain ordered microdomain platforms that 
concentrate and organize lipids and proteins required for specific functions such as fusion 1–7. 
Membrane microdomains are usually enriched in signaling lipids including phosphoinositides, 
sterols, and sphingolipids as well as their modified derivatives. Fusion events are essential for 
cellular homeostasis and understanding the regulation and mechanics of membrane fusion can 
shed light on understanding diseases that subvert these pathways. 
 We use lysosomal vacuoles from the yeast Saccharomyces cerevisiae as a model 
system to test the role of signaling lipids in membrane fusion. The fusion pathway is initiated 
when the AAA+ Sec18/NSF (N-ethylmaleimide sensitive factor) associates with Sec17/α-SNAP 
(Soluble NSF adaptor protein) bound to inactive cis-SNARE (SNAP receptor) complexes 8. The 
ATPase activity of Sec18 leads to conformational changes that are transferred to -SNAP, which 




priming. Although most SNAREs are anchored to membranes, the vacuolar Qc-SNARE Vam7 is 
soluble and is released from the membrane upon priming 9. Vam7 re-associates with the 
organelle during the docking stage through the interaction of its PX domain with the lipid 
phosphatidylinositol 3-phosphate (PI3P) and subsequently enters into trans-SNARE complexes 
via its SNARE motif 10–13. The formation of trans-SNARE complexes between partnered vesicles 
triggers the release of luminal Ca2+ stores 14. During the tethering and docking stages, vacuoles 
become tightly apposed forming a flattened domain termed the boundary membrane. The 
edge of the boundary, where membranes come into contact becomes enriched in the proteins 
and lipids that promote fusion 2,6,7. This membrane microdomain is termed the vertex ring and 
is the site of fusion. Fusion can occur directly through the formation of a fusion pore or through 
an intermediate hemifusion state where the outer leaflets of membrane mix without fusing the 
inner leaflets, thus preventing content mixing 15–18. Full fusion occurs when both leaflets fuse 
and luminal contents are mixed.  
Each stage of vacuole fusion is affected by signaling lipids through distinct roles. 
Phosphatidic acid (PA) is converted to diacylglycerol (DAG) at the priming stage by the PA 
phosphatase Pah1 to facilitate the transfer of Sec18 from PA-enriched membrane domains to 
cis-SNARE complexes (Starr & Fratti, submitted) 19,20. Ergosterol and PI(4,5)P2 function during 
priming by unknown mechanisms, as well as late in the pathway where they affect actin 
remodeling 21–23. DAG functions after trans-SNARE pairing where it is thought to destabilize 
membrane bilayers to promote fusion 2,12,24. PI3P is made by Vps34 during the fusion cascade 
where it recruits Vam7 as well as the Ypt7 GEF Mon1-Ccz1 11,25. Phosphoinositides also aid in 




addition to these effects, signaling lipids are essential for the organization of the proteins and 
lipids at the vertex ring in an interdependent manner 2.  
Vam7 is a unique SNARE in that it lacks a membrane anchor be it proteinaceous or 
lipidic 10. Instead it associates with the membrane through its N-terminal PX domain that binds 
both PI3P and the HOPS complex 11,26,27. Binding to PI3P and fusion are inhibited by the Y42A 
mutation 11,12. Vam7 also interacts with the vacuole through its interactions with through its C-
terminal SNARE motif that binds its cognate SNAREs as well as the HOPS subunit Vps33 28. 
Vam7-triggered fusion is blocked by the Q283R mutation in the ionic zero layer of the SNARE 
motif, which stalls the fusion pathway in a hemifusion state 18,29. Vam7 is also recruited to 
vacuoles through a mechanism dependent on the ABC transporter Ycf1 through an unknown 
mechanism 30. Vam7 contains a putative alpha helical middle domain that is uncharacterized. In 
further examining the properties of the middle domain we identified a polybasic region (PBR) 
containing six Arg and Lys in the third alpha helix near the SNARE domain. Mutagenesis of the 
region was performed converting all of the basic residues to alanine (Vam7-6A). We report that 
the PBR affects PI3P binding and protein interactions with SNAREs and HOPS needed for 
efficient vacuole fusion. 
RESULTS 
The polybasic region of the Vam7 middle domain is required for efficient homotypic fusion  
In previous studies others and we have examined how the PX and SNARE domains of the 
soluble Qc-SNARE Vam7 interacts with the vacuole to stimulate fusion. Here we examined the 




which is predicted to be a -helical structure. The -helix closest to the SNARE domain has a 
polybasic face with six Arg and Lys in close proximity (Fig. 1A). We mutated each of these basic 
residues to alanine to construct Vam7-6A. To test the ability of Vam7-6A to stimulate fusion we 
employed a well-characterized bypass assay where priming is inhibited by anti-Sec17 IgG 
12,14,29,31. Recombinant GST-Vam7 can be added to these blocked in vitro reactions to stimulate 
fusion. Soluble Vam7 can interact with free Vam3, Vti1 and Nvy1 to form trans-SNARE pairs at 
the docking stage. We found that wild type Vam7 robustly stimulated fusion as observed 
previously where as Vam7-6A was impaired (Fig. 1B). Although Vam7-6A could support fusion, 
it required far higher concentrations relative to wild type resulting in a significant right-shift at 
the half maximal efficacy values. The EC50 of wild type Vam7 was 42.2 14.8 nM, where as the 
EC50 for Vam7-6A was 153.1  46.1 nM. The biphasic curve seen with Vam7 is characteristic of 
the anti-Sec17 bypass. The inhibitory effect at high concentrations is thought to be due to 
competition for HOPS and PI3P on the membrane 29. We next examined Vam7-6A in a standard 
fusion assay in the absence of any inhibitor. Wild type Vam7 has a slight stimulatory effect on 
fusion as previously observed. On the other hand, Vam7-6A lacked the stimulatory effect and 
rather inhibited fusion at concentrations above 300 nM (Fig. 1C).  
The inhibitory effect of Vam7-6A led us to ask if the protein was structurally unstable. To 
examine if mutating the PBR affected protein stability we used Differential Scanning 
Fluorimetry. Figure 1D shows the first derivative of thermal melt curves for wild type Vam7 and 
Vam7-6A. The Tm for both proteins was 55C, indicating that mutating the PBR did not have a 




Vam7-6A bypass of anti-Sec17 IgG blocked fusion promotes lipid mixing 
Others have shown that fusion can occur rapidly by making a direct fusion pore, or 
through a slower pathway that goes through a hemifusion intermediate 15,17. During 
hemifusion, the outer leaflets of docked vesicles fuse leaving the inner leaflets intact to prevent 
the mixing of luminal content. Vacuole homotypic fusion can also go through a hemifusion 
intermediate and mutations in SNAREs can stall the pathway at this stage 16,18. For instance 
Vam7Q283R can form SNARE complexes but cannot trigger full fusion of vacuoles blocked with 
anti-Sec17 antibody. However, Vam7Q283R could trigger lipid mixing of the outer leaflet as 
efficiently as wild type Vam7, indicating that the mutant SNARE could only promote hemifusion 
and not full bilayer mixing. In this study we saw that Vam7-6A was attenuated in the bypass of 
anti-Sec17 IgG inhibited priming. To determine if Vam7-6A containing reactions were stalled 
before or after a hemifusion stage we employed the previously described lipid-mixing assay. 
Here, a population of vacuoles was labeled with Rh-PE and mixed with a 8-fold excess of 
unlabeled vacuoles. Rh-PE is limited to the outer leaflet and self-quenches at elevated 
concentrations. Rh-PE fluorescence de-quenches when the outer leaflets of membranes fuse to 
dilute the fluorophore. The kinetics of lipid mixing and content mixing are separated by up to 
60 min 32. Using vacuoles treated with anti-Sec17 IgG we found that both 100 nM Vam7 and 
Vam7-6A promoted Rh-PE fluorescence de-quenching (Fig. 1E, F). However the effectiveness of 
Vam7-6A to promote lipid mixing was reduced by 10% relative to wild type. Importantly, 
content mixing was reduced by 50% when comparing 100 nM Vam7-6A to wild type Vam7. 




while having diminished content mixing. Thus, it appears that there is a delay between a 
hemifusion stage and full bilayer mixing.  
Expression of Vam7-6A in vivo  
To test the effects of mutating the Vam7 PBR in vivo we expressed plasmid encoded 
wild type Vam7 and Vam7-6A in vam7 cells and examined vacuole morphology. Figure 2A 
shows cells incubated with the vital dye FM4-64. Wild type cells showed the characteristic 
vacuole staining where as vam7 cells lacked intact vacuoles and the dye labeled scattered 
puncta throughout the cell. In addition, it vam7 cells appeared to have an endocytic defect as 
a significant portion of FM4-64 remained on the plasma membrane. The vacuole morphology 
defect was rescued with plasmid encoded Vam7. Similarly Vam7-6A expression restored 
vacuole structure. Although Vam7-6A restored vacuole morphology it is not sufficient to restore 
defective vacuole fusion in vitro. Because Vam7 is soluble and associates with membrane 
proteins and lipids we next examined Vam7 partitioning between the vacuole and cytosol. 
Defects in membrane binding would be evident by a shift to the cytosolic fraction as seen 
previously with Vam7Y42A 11 or in the absence of the ABC protein Ycf1 30. Our fractionation 
experiments showed there was no difference in the distribution of Vam7 and Vam7-6A.  
Vam7-6A is inhibited in the bypass of multiple fusion blocks 
In the first figure we showed that Vam7-6A was unable to fully support fusion when 
SNARE priming was blocked with anti-Sec17 IgG. We next asked if Vam7-6A could bypass other 
inhibitors relative to wild type Vam7. First we tested a second inhibitor of priming. Previously 




study we showed that Vam7 was able to bypass the propranolol fusion block. Here we tested 
the ability of wild type Vam7 and Vam7-6A in rescuing the propranolol block. Fusion rescue was 
compared to uninhibited fusion that was normalized to 100%. We found that Vam7-6A was 
inhibited in its ability to support fusion relative to wild type (Fig. 3A). The apparent EC50 of wild 
type Vam7 was 150 nM where as 375 nM of Vam7-6A was required for the same level of fusion. 
Due to the fusogenicity of DAG it is possible that a reduction in its production from PA 
increased the energy threshold needed for fusion to be triggered by Vam7 and that Vam7-6A 
function did not generate sufficient energy to do so. It is also possible that the PBR affects the 
interaction with the other SNAREs resulting in the absence of fusion. Perhaps the PBR interacts 
electrostatically with the acidic lipids of the membrane and/or acidic protein surfaces. Thus, the 
Vam7-6A would abolish electrostatic interactions and reduce its ability to support maximal 
fusion.  
One of the ways that Vam7 interacts with the vacuole is through the binding of PI3P by 
its N-terminal PX domain 11. The PI3P binding property of the PX domain can be inhibited by the 
Y42A mutation, which also severely attenuates the ability of Vam7 to bypass an anti-Sec17 IgG 
block 12. The PX domain alone binds to the HOPS complex and can block fusion when added to 
fusion reactions containing endogenous levels of full length Vam7 9,26. The addition of 
exogenous Vam7 can partially overcome the inhibitory effect of the PX domain 14,33. Here we 
found that Vam7-6A was unable to rescue the PX block compared to the effect of the wild type 
SNARE (Fig. 3B). This could be due to conformational changes in Vam7-6A that prevents 




Thus far we tested the ability of Vam7 to bypass blocks that target early steps in the 
reaction pathway. We next tested if Vam7-6A can bypass late blocks as effectively as its wild 
type parent. A key signaling lipid involved in fusion is PI(4,5)P2, which is made during the fusion 
reaction and is required for the assembly of the vertex ring at the docking stage and for 
regulating actin dynamics 21,23. PI(4,5)P2 serves additional unknown functions during priming 
and after trans-SNARE pair formation 22,24. Converting PI(4,5)P2 to PI4P with the PI 5-
phosphatase SigD, blocks trans-SNARE pairing 34. The addition of recombinant Vam7 had 
previously been shown to bypass the effects of SigD 18. Here we found that Vam7-6A was able 
to bypass the SigD block, albeit with reduced efficacy compared to wild type Vam7 (Fig. 3C). 
This suggests that the Vam7 PBR plays a more important role in early stages of the fusion 
pathway.  
To test another late acting lipid we examined the bypass of blocking fusion with the DAG 
ligand C1b. We previously found that Vam7 could rescue C1b blocked fusion in the presence of 
chlorpromazine, an amphipathic cation that increases membrane fluidity and induces negative 
membrane curvature 18,35. DAG accumulates at the boundary membrane and vertex 
microdomain where it is thought to destabilize the bilayer to facilitate fusion after docking 2. 
The DAG ligand C1b disrupts the vertex ring, which would disperse the bilayer destabilizing 
effects of DAG. Chlorpromazine reduces membrane tension and is theorized to lower the fusion 
energy barrier threshold to allow Vam7 to stimulate fusion in the presence of C1b. Here we 
compared ability of wild type and Vam7-6A to bypass the C1b block in the presence 
chlorpromazine. Similar to what we found with the SigD bypass, we found that both wild type 




the effective dose of Vam7-6A required to support fusion at same level as seen with the wild 
type protein (Fig. 3D). This is consistent with the notion that the Vam7 PBR is more important 
at earlier stages of the fusion pathway. 
Vam7-6A does not rescue the defective fusion of ycf1Δ vacuoles  
Until recently, the recruitment of Vam7 to vacuoles was thought to only depend on its 
interactions with PI3P, HOPS and its cognate SNAREs. However, we found that the class C ABC 
transporter Ycf1 was also needed for Vam7 recruitment. The deletion of YCF1 led to a reduction 
in vacuolar Vam7 that was linked to inhibited fusion 30. Importantly, the fusion defect observed 
with ycf1 vacuoles was rescued by the addition of recombinant Vam7 during the fusion 
reaction. Here, we tested if the Vam7 PBR was required for the rescue of attenuated ycf1 
fusion. For the purpose of this paper we normalized fusion to the levels of untreated ycf1 
vacuoles, which show a 40% reduction in fusion when compared to wild type vacuoles. We 
found that Vam7-6A was unable to increase ycf1 fusion, where as wild type Vam7 enhanced 
the fusion of ycf1 vacuoles to wild type levels as seen previously (Fig. 3E). These data suggest 
that additional interactions are between Vam7 and vacuolar constituents occur that require an 
intact PBR.  
Vam7-6A shows diminished interaction with SNAREs and HOPS 
In the previous experiments we showed under various conditions that Vam7-6A was 
unable to promote robust fusion suggesting that the PBR plays an important role in Vam7 
function. We next tested if the PBR domain would affect the formation of SNARE complexes or 




IgG bypass reactions for the isolation of protein complexes 12,29. SNARE priming was blocked by 
the addition of anti-Sec17 IgG to reactions. After incubating for 15 min, secondary inhibitors 
were added followed by an additional 5 min of incubation. Next, 150 nM GST-Vam7 or GST-
Vam7-6A was added to bypass the anti-Sec17 IgG block. Fusion reactions were incubated for a 
total of 90 min after which membranes were processed for GST-Vam7 isolation as described in 
the Experimental Procedures. The secondary inhibitors Gyp1-46 and propranolol were used to 
inhibit Ypt7 and Pah1 function, respectively. The Western blots show that wild type Vam7 was 
able to form protein complexes with the syntaxin homologue Vam3, the R-SNARE Nyv1 and the 
HOPS subunit Vps16 (Fig. 4A-B). The formation of these complexes was inhibited by both Gyp1-
46 and propranolol. It should be noted that although Vam7 can bypass fusion blocked by 
propranolol alone, it is unable to do so when used in combination with anti-Sec17 IgG. Vam7-6A 
showed a significant reduction in binding to the SNAREs Vam3 and Nyv1 as well as the HOPS 
complex (Fig. 4A-B). The reduced amount of Vam7-6A protein complexes was further reduced 
by Gyp1-46 and propranolol as seen with wild type Vam7. These data indicate the Vam7 PBR is 
required for the efficient formation of protein complexes.  
The formation of SNARE complexes is linked to the release of luminal Ca2+ stores and 
changes in the homeostasis of Ca2+ transport has been associated to fusion efficiency 14,36. In 
this study we have seen that the Vam7 PBR is essential for the optimal function. Vam7-6A is 
unable to fully bypass fusion blocks that wild type Vam7 supports. This difference is due in part 
to the reduced ability of Vam7-6A to form protein complexes with its partner SNAREs. We next 
asked if the reduced interactions with SNAREs and HOPS directly affected Ca2+ release. Fusion 




blocked for priming were supplemented with buffer, wild type Vam7 or Vam7-6A. Ca2+ 
transport was detected by changes in Fluo-4 fluorescence. In all conditions we first observed 
the uptake of Ca2+ from the media as detected by the reduction in Fluo-4 fluorescence. The 
untreated control began to efflux Ca2+ at 10 min and plateaued after 17-18 min. The reactions 
treated with anti-Sec17 continued to uptake extraluminal Ca2+ until the addition of Vam7. This 
data showed that both wild type Vam7 and Vam7-6A triggered the release of Ca2+ from the 
vacuole lumen (Fig. 4C-D). Vam7-6A appeared to release less Ca2+ compared to wild type. 
Figure 4B shows the averaged of three experiments with two concentrations of Vam7. 
Importantly, we observed that the initial rate of Ca2+ release was slower with Vam7-6A. When 
the rates of Ca2+ release were fitted to kinetic curves we found that wild type Vam7 stimulated 
half maximal release of 1.03 nM Ca2+ sec-1. Vam7-6A data showed half maximal release of 0.48 
nM Ca2+ sec-1. Together this suggests that wild type Vam7 is fully engaged in forming trans-
SNARE complexes that trigger Ca2+ efflux. The reduced rate of release seen with Vam7-6A is 
indicative of this SNARE interacting with another ligand apart from trans-SNARE complexes. 
Because Vam7 binds to the membrane through its PX domain it is possible that wild type Vam7 
sequentially binds to PI3P and SNAREs, whereas Vam7-6A may remain associated to the 
membrane while forming SNARE complexes. Thus, it is important to test for differential 
membrane binding by Vam7 and Vam-6A. 
Mutating the Vam7 PBR does not alter net vacuole association 
We next examined if the Vam7 PBR was required for its association with vacuoles. To 




vacuoles treated with anti-Sec17 IgG. After incubating for 10 min at 30C the vacuoles were re-
isolated by centrifugation and separated from the supernatant fraction. Bound GST-Vam7 was 
detected by Western blotting. In Figure 5 it is shown that both wild type and Vam7-6A 
associated with vacuoles equally well. This is in contrast to Figure 3 where we found that Vam7-
6A was attenuated in its interaction with other SNAREs and HOPS. Together this suggests that 
the wild type levels of overall vacuole association by Vam7-6A were due to other interactions, 
such as those with membrane lipids.   
The Vam7 PBR affects binding to PI3P by the PX domain 
Polybasic regions of various proteins have been shown to interact with anionic lipids. To 
examine if the Vam7 PBR affects binding to lipids we used a liposome-binding assay. In these 
assays we reconstituted liposomes composed of PC and PE alone or in the presence of a 
signaling lipid. Recombinant Vam7 was incubated with liposomes after which the membranes 
were isolated by flotation. Bound Vam7 floated with liposomes if there was a direct interaction. 
In Figure 6A we show that wild type Vam7 bound well to PI3P. This was expected as the PX 
domain preferentially interacts with PI3P 11. There were only trace amounts of Vam7 that 
associated with PC/PE liposomes. The lower panel showed quantitation of three experiments 
where binding was normalized to PC/PE liposomes and wild type Vam7. In addition to PI3P we 
also included liposomes that contained PA, DAG or PS. Vam7 did not interact with either DAG or 
PS. PA liposomes showed limited binding to Vam7. When Vam7-6A was tested we found that 
binding to PI3P was increased by nearly three-fold. The increase in PI3P binding was not 




interaction of Vam7-6A with PA, DAG and PS was similar to binding by wild type Vam7. This was 
curious as we expected the removal of a multiple basic residues to reduce lipid binding. This led 
us to hypothesize that the Vam7 PBR affects the ability of the PX to bind PI3P.  
To determine if mutating the Vam7 PBR affected interactions with other lipids, we 
performed similar flotation assays with other phosphoinositides. In Figure 6B we tested Vam7 
binding to PI alone as well as PI4P and PI5P. We found that both wild type Vam7 and Vam7-6A 
floated with PI5P containing liposomes. The binding to PI5P is not unexpected as Cheever et al. 
showed that the PX alone could bind to PI5P by lipid overlay assays 11. The role of PI5P in 
membrane trafficking is not well understood. That said, Boal et al. showed that the endosomal 
protein TOM1 interacts with PI5P to regulate endosomal maturation 37. Thus it is possible that 
Vam7 interactions with other phosphoinositides could be part of its function. We also detected 
equivalent low levels of binding of Vam7 and Vam7-6A to PI and PI4P. These interactions were 
near the level of baseline interactions to PC/PE liposomes. To complete the liposome binding 
experiments we tested polyphosphorylated phosphoinositides. Liposomes were constructed 
containing PC/PE and either PI(3,4)P2, PI(3,5)P2, PI(4,5)P2, or PI(3,4,5)P3. These experiments 
showed that neither Vam7 nor Vam7-6A interacted with PI(3,5)P2, PI(4,5)P2, or PI(3,4,5)P3 (Data 
not shown). Interestingly, we did find that both Vam7 and Vam7-6A interacted modestly with 
PI(3,4)P2 and mutating the PBR increased binding to the lipid, but the difference was not 
statistically significant. PI(3,4)P2 is not well characterized in its role in membrane trafficking. 
This unusual lipid is made by Class II PI3kinases that convert PI4P to PI(3,4)P2 
38,39. PI(3,4)P2 is 
also made by the dephosphorylation of PI(3,4,5)P3 




in yeast we conclude that the binding of Vam7 constructs to PI(3,4)P2 is not biologically 
relevant.  
Because Vam7-6A binds to PI3P relative to wild type we theorized that the PBR affects 
PI3P binding by the PX domain. Previous studies have shown that mutating the PX critical Y42 
inhibited binding to PI3P and severely blocked vacuole fusion 11,12. Computer structure 
predictions indicate that the surface of the Vam7 PX domain contains two acidic patches that 
could in theory interact with the basic charges of the PBR. To test this notion we made the Y42A 
mutation in Vam7-6A to produce Vam7-7A. We compared PI3P binding by Vam7-7A to that of 
wild type Vam7, Vam7-6A and Vam7Y42A. Our data show that Vam7Y42A had reduced binding to 
PI3P (Fig. 7A). Importantly, Vam7-7A binding to PI3P was below the level of Vam7Y42A. This is 
consistent with the idea that the Vam7 PBR does not directly bind lipids but rather affects the 
lipid binding ability of a separate domain. We now postulate that the Vam7 PBR affects PI3P 
binding by the PX domain.  
Due to the increased PI3P binding caused by mutating the PBR we next tested how 
Vam7-6A lipid binding compared to the PX domain alone. Our data showed that the enhanced 
PI3P binding of Vam7-6A was equivalent to that seen with the PX domain alone (Fig. 7B). This is 
consistent with the notion that other domains in Vam7 regulate lipid binding by the PX domain. 
At this point we cannot distinguish whether the differences in PI3P binding were due to 
changes in binding affinity or undefined steric effects. Nevertheless, we can conclude that PI3P 






Homotypic vacuole fusion requires the R-SNARE Nyv1 and the Q-SNAREs Vam7, Vam3 
and Vti1. Vam7 is a unique SNARE in that it lacks a transmembrane helix or lipid moiety to 
anchor it to the membrane. Instead Vam7 associates to the membrane via an N-terminal PX 
domain that interacts with the lipid PI3P and the HOPS complex. Previous studies have focused 
on either the PX domain or the C-terminal SNARE motif. Vam7 also has a middle domain that 
had not been characterized. One of the predicted features of the Vam7 middle domain is an 
alpha helix with a polybasic face containing six Lys and Arg in close proximity that we refer to as 
the polybasic region, or PBR. In this study we examined the role of the Vam7 PBR in supporting 
vacuole homotypic fusion. 
Many proteins across diverse pathways contain PBRs that are associated with binding 
anionic lipids including PS, PA and PIs. Vam7 is not the only SNARE that contains a PBR. The Q-
SNARE Spo20 contains an amphipathic helix with a polybasic face that binds PA on prospores 
and the plasma membrane as a positive regulator of the protein 41. Its binding to PA depends 
on the presence of the acidic lipids PS and PI(4,5)P2 
42. In mammalian cells syntaxin1 contains a 
PBR that binds to various PIs on lipid overlay experiments, while liposome binding shows that it 
preferentially binds to PA 43. The syntaxin1 PBR regulates fusion pore dynamics and mutating 
basic residues to Ala alters secretion. We originally hypothesized that the Vam7 PBR would 
contribute to membrane binding by directly interacting with vacuolar acidic lipids. However, 
contrary to what we expected, we found that mutating the basic residues of the PBR to alanines 




would affect lipid binding, but incorrect in that the Vam7-6A mutant would exhibit reduced 
binding due to disrupting the interactions between membrane lipids and the PBR domain.  
How does the Vam7 PBR affect fusion? In order to reconcile the increased binding of 
Vam7-6A to PI3P with the reduced ability to support fusion we must consider two things. First, 
Vam7-6A showed a marked decrease in protein binding to its cognate SNAREs and HOPS. 
Second, the overall association of Vam7-6A with vacuoles was indistinguishable from wild type 
Vam7. Together this suggests that the increased binding of Vam7-6A to PI3P and decreased 
binding to SNAREs and HOPS cancel each other out to show an over all “wild type” vacuole 
association. Another question is how does this translate to the attenuated fusion phenotype? In 
addition to SNARE complex formation, vacuole fusion requires the downstream release of 
luminal Ca2+ stores. Our data showed that Vam7-6A triggered reduced Ca2+ efflux with slower 
initial rate relative to wild type Vam7. The fast initial Ca2+ efflux rate triggered by wild type 
Vam7 suggests that it is operating at “saturation”, meaning that it fully participating in SNARE 
complexes. The slower rate of Ca2+ release triggered by Vam7-6A suggests that it is at sub-
saturation in the forming SNARE complexes and is likely binding a second ligand. Because 
Vam7-6A bound PI3P more than the wild type protein we theorize that it remains bound to 
PI3P while forming SNARE complexes. This leads us to postulate that wild type Vam7 first binds 
PI3P and subsequently releases the lipid as it enters into SNARE complexes. Retention of Vam7-
6A by PI3P could possible reduce its ability to be transferred to nascent trans-SNARE 
complexes. The reduced number of SNARE bundles would generate and transfer less energy to 




In our model the Vam7 PBR affects PI3P binding by the PX domain. We propose that this 
occurs through a direct interaction between the positive charges of the PBR and the negatively 
charged surface of the PX domain. Our homology modeling with the PX domain of p40phox 
indicates that there are two acidic patches on the Vam7 PX domain where the PBR domain 
could electrostatically interact. This interaction could potentially reduce the affinity or access of 
the PX to PI3P in order to facilitate SNARE complex formation. Therefore, mutating the basic 
PBR residues to Ala would disrupt the electrostatic interaction with the PX domain, leading to 
increased PI3P binding at the sacrifice of optimal SNARE interactions. This model is supported 
by our data showing that mutating the critical PX Tyr (Y42A) in Vam7-7A abolished the 
augmented PI3P binding of Vam7-6A.  
In addition to the PX domain there are other acidic surfaces on the vacuole that could 
potentially interact with the Vam7 PBR. For instance the surface of SNARE four-helical bundles 
is acidic. Thus, it is possible that the Vam7 PBR interacts with the SNARE bundle in order to 
stabilize the complex and promote the transfer of energy to the membrane. The lack of 
interactions of the PBR with the acidic surface of SNARE bundle could reduce the energy 
transferred to the membrane resulting in a stall between a hemifusion intermediate and full 
content mixing. In turn, conformational changes could affect PI3P binding by the PX domain. 
EXPERIMENTAL PROCEDURES 
Reagents 
Soluble reagents were dissolved in PIPES-Sorbitol buffer (20 mM PIPES-KOH, pH 6.8, 200 




PX 12, GST-FYVE 44, His6-SigD 
2, His6-Gyp1-46 
7 and GST-C1b 45 and Pbi2 46 were prepared as 
described previously. Phosphatidylcholine (PC; 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphatidycholine), phosphatidylethanolamine (PE; 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphatidyethanolamine), phosphatidylserine (PS; 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphatidylserine), diacylglycerol (DAG; 1-palmitoyl-2-oleoyl-sn-glycerol), phosphatidic acid 
(POPA; 1,2-dipalmitoyl-sn-glycero-3-phosphate), diC8-PA (1,2-dioctanoyl-sn-glycero-3-
phosphate), and diC8-DAG (1,2-dioctanoyl-sn-glycerol) were purchased from Avanti Polar Lipids 
(Alabaster, AL). Phosphatidylinositol (PI; 1,2-dipalmitoyl phosphatidylinositol), PI 3-phosphate 
(PI3P; 1,2-dipalmitoyl phosphatidylinositol 3-phosphate), PI4P, PI5P, PI(3,4)P2, PI(3,5)P2, 
PI(4,5)P2 and PI(3,4,5)P3 were purchased from Echelon Biosciences Incorporated (Salt Lake City, 
UT). Chlorpromazine (Sigma) was stored as a 4.5 mM stock solution in dimethyl sulfoxide. 
Propranolol (Sigma) was dissolved in PIPES-Sorbitol buffer.   
Recombinant GST-Vam7 constructs 
The previously described pET42a constructs encoding Vam7 and Vam7Y42A were used for 
expressing recombinant GST fusions and to generate new mutants 12,29. Site directed 
mutagenesis was carried out using pET42a-Vam7 to change R164, R168, K172, K175, R179 and 
K186 to alanines to generate Vam7-6A using the primers listed in Table 1. In addition, the Y42A 
mutation was made in Vam7-6A to produce Vam7-7A. All GST-Vam7 constructs were 
recombinantly expressed as described previously 12,29.  




Vam7 was amplified from BJ3505 genomic DNA beginning 308 bases upstream and 
ending 308 bases downstream using SOEing primer 1 and SOEing primer 7. The DNA was 
purified and digested with BamH1-HF and EcoR1-HF. After purification the cut DNA was ligated 
with pRS413 that was digested with BamH1-HF and EcoR1-HF and CIP treated. Purified ligated 
DNA was transformed into NEB Turbo competent E. coli cells and selected for on Luria broth 
with Ampicillin. Plasmid was isolated from transformants and fidelity was confirmed by 
sequencing using M13 forward and reverse primers. Plasmid was transformed into DKY6281 
vam7 yeast and selected for on complete synthetic media lacking tryptophan and histidine to 
make RFY70.  
Vam7-6A was amplified in three pieces. The 5' untranslated region was amplified from 
BJ3505 genomic DNA using SOEing primer 1 and SOEing primer 2. The 3’ untranslated region 
was amplified from BJ3505 genomic DNA using SOEing primer 5 and SOEing primer 7. The open 
reading frame of Vam7-6A was amplified from pET42a-VAM7-6A plasmid using SOEing primer 3 
and SOEing primer 4. PCR products were purified and then combined via SOEing reaction (62 C 
annealing; 72C extension, 45 sec; 15 cycles), followed by the addition of SOEing primer 1 and 
SOEing primer 7 (62C annealing; 72C extension, 1 min; 29 cycles). The band at proper size was 
gel extracted and then followed the above procedure for cloning Vam7 in to pRS413 to make 
RFY71. 
Vacuole isolation and in vitro fusion 
Vacuoles were isolated from the S. cerevisiae strains BJ3505 and DKY6281 as described 




fusion reactions (30 µl) contained 3 µg each of vacuoles from BJ3505 (PHO8 pep4) and 
DKY6281 (pho8 PEP4) backgrounds, fusion reaction buffer (20 mM PIPES-KOH pH 6.8, 200 mM 
sorbitol, 125 mM KCl, 5 mM MgCl2), ATP regenerating system (1 mM ATP, 0.1 mg/ml creatine 
kinase, 29 mM creatine phosphate), 10 M coenzyme A, and 283 nM Pbi2. Fusion was 
determined by the activation of pro-alkaline phosphatase (proPho8) by the protease Pep4. 
Fusion reaction mixtures were incubated at 27C for 90 min after which the vacuoles were 
lysed in 250 mM Tris-Cl, pH 8.5, 0.4% Triton X-100, 10 mM MgCl2, and 1 mM p-nitrophenyl 
phosphate. Mature Pho8 activity was assayed through the dephosphorylation of p-nitrophenyl 
phosphate to generate p-nitrophenolate. Fusion units were measured by determining the p-
nitrophenolate produced, which was measured at 400 nm. Yeast cytosol was prepared as 
described previously 48. Cells expressing Vam7 or Vam7-6A were disrupted by vortexing with 
glass beads in the presence of protease inhibitors. Lysates were centrifuged to remove large 
debris and supernatants were transferred to ultracentrifuge tubes and membranes were 
pelleted by centrifugation (100,000 x g, 1 h, 4C). The supernatants were collected as the 
cytosol fractions. 
GST-Vam7 pulldown 
GST-Vam7 protein complex isolation was performed as described 12,29. Large-scale 6X 
fusion reactions (180 µl) were incubated with 85 µg/ml anti-Sec17 IgG to block priming. After 
15 min, 0.5 µM Gyp1-46 or 2 mM propranolol was added to selected reactions and incubated 
for an additional 5 min adding buffer or 150 nM GST-Vam7. After at total of 90 min, reactions 




remaining vacuoles were re-isolated by centrifugation (11,000 X g, 10 min, 4C), and the 
supernatants decanted before extracting vacuoles with solubilization buffer (SB: 20 mM HEPES-
KOH, pH 7.4, 100 mM NaCl, 2 mM EDTA, 20% glycerol, 0.5% Triton X-100, 1 mM DTT) with 
protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 10 M Pefabloc-SC, 5 M pepstatin A, 
and 1 M leupeptin). Vacuole pellets were gently resuspended with 200 µl SB and incubation 
for 20 min on ice. Insoluble debris was sedimented by centrifugation (16,000 X g, 10 min, 4C), 
and 176 µl of supernatants were transferred to new chilled tubes. Next, 16 l was removed 
from each reaction as 10% total samples, mixed with SDS loading buffer and heated (95C, 5 
min). The remaining extracts were incubated with 30 µl equilibrated glutathione Sepharose 4B 
beads (GE Healthcare) (12 h, 4C, nutating). Beads were sedimented (735 X g, 2 min, 4C) and 
washed with 1 ml SB five times, and bound material was eluted with SDS loading buffer. Protein 
complexes were examined by western blotting.  
Calcium Efflux 
Vacuole lumen Ca2+ efflux was measured as described 36. Fusion reactions (2X) 
contained 20 µg of vacuoles isolated from BJ3505, fusion reaction buffer with 10 µM CoA, and 
283 nM Pbi2 and the fluorescent Ca2+ probe Fluo-4 dextran at 150 nM (Invitrogen). Reaction 
mixtures were transferred to a black, half-volume 96-well flat-bottom plate with nonbinding 
surface (Corning). ATP regenerating system, or buffer was added and reactions were incubated 
at 27C while monitoring Fluo-4 fluorescence. Samples were analyzed in a fluorescence plate 




were initiated with the addition of ATP regenerating system when the start of measurement 
subsequently followed. Calibration was done using buffered Ca2+ standards (Invitrogen). 
Liposome Preparation and Co-Floatation Assay 
Small unilamellar liposomes containing specific lipid compositions were produced by 
sonication 49. Stock lipids dissolved in chloroform were mixed to produce a mixture with the 
desired mole percentages of 2.6 µmoles of total phospholipids. Samples were then placed 
under vacuum in a desiccator for an additional 14 h. PBS (2.6 ml) was added to the dried lipids 
and the tubes were covered with parafilm and incubated at room temperature for 1 h. The 
lipids were suspended with vortexing and disrupted in a water bath sonicator for 30 min. To 
measure protein binding to the liposomes we used a floatation assay as described 50. Liposome 
binding was conducted by adding 150 nM Vam7 to prepared liposomes (150 µl). Samples were 
incubated for 10 min at 30ºC and 630 µl of 1.65 M sucrose (PBS) was added. Samples were 
loaded into the bottom of a centrifuge tube and overlaid with 630 µl of 0.75 M sucrose (PBS), 
and 1X PBS to the top of the tube. Samples were centrifuged (200,000 x g, 90 min, 4ºC) and 200 
µl of floated liposomes were recovered from the top of the 0.75 M sucrose layer. The bottom 
100 µl fraction was recovered and SDS sample buffer was added to detect unbound protein 
levels. Liposomes were diluted in 2 ml of 1X PBS and isolated by centrifugation (16,000 x g, 20 
min, 4ºC). SDS sample buffer was added to the final liposome pellet and bound proteins were 
resolved by SDS-PAGE. The proteins were transferred to nitrocellulose and probed by Western 





Lipid Mixing assays were conducted using rhodamine B DHPE (Rh-PE; Thermo Fisher) as 
described 48. BJ3505 vacuoles (300 µg) were isolated and then incubated in 400 µl of PS buffer 
containing 150 µM Rh-PE (10 min, 4°C, nutating). Next, 800 µl of 15% Ficoll was added and then 
transferred to an 11 x 60 mm ultracentrifuge tube, overlaid with 1.2 ml of 8% and 4%, and 0.5 
ml of PIPES-Sorbitol buffer. Labeled vacuoles were isolated by centrifugation (105,200 X g, 25 
min, 4°C, SW-60 Ti rotor) and recovered from the 0-4% Ficoll interface. Lipid mixing assays (90 
µl) contained 2 µg of labeled vacuoles and 16 µg of unlabeled vacuoles in fusion buffer. 
Reaction mixtures were transferred to a black, half volume 96-well flat-bottom microtiter plate 
on ice. The plate was transferred to a fluorescence plate reader at 27°C to start the reactions. 
Measurements were taken every 60 sec for 50 min, yielding fluorescence values at the onset 
(F0) and during the reaction (Ft). After 40 min 0.45% (vol/vol) Triton X-100 was added and the 
final 10 measurements were averaged to give the value of fluorescence after infinite dilution 
(FTX100). The relative fluorescence change ΔFt/FTX100 = (Ft - F0)/FTX100 - F0 was calculated. 
Differential Scanning Fluorimetry 
Wild type Vam7 and Vam7-6A were diluted in PS buffer with 125 mM KCl and 10% 
glycerol to a final concentration of 0.43 mg/ml with. SYPRO orange dye (6x) was added to the 
reactions and 25 l of mix was added to a white Bio-Rad hard-shell 96-well PCR plate and 
covered with optical Microseal "b" Adhesive seal. Samples equilibrated for 30 min prior to 
starting the melting curve. This was run on a Bio-Rad CFX connect Real-Timer PCR Detection 
System. The PRC protocol was 20C for 1 min followed by 20C – 95C temperature gradient 




temperature (ex = 490 nm, em = 560 nm). The first derivatives of the fluorescence data were 
used to determine the Tm for each sample. 
Microscopy 
Vacuole morphology was detected by incubating cells with 5 M FM4-64 IN YPD broth 
(Invitrogen) as described previously 36. Images were acquired with a Zeiss Axio Observer Z1 
inverted microscope with an X-Cite 120LX light source, a Plan Apochromat 63X oil objective (1.4 
N.A.), and AxioCam CCD camera. FM4-64 images were acquired using a 43 HE Cy3 shift-free 
filter set. Z-stacks of images were taken and images were deconvolved using AxioVision 3D 
software.  
Statistical analysis 
All statistical analysis was calculated using one-way ANOVA. P values of ≤ 0.05 were 
considered significant. Ca2+ efflux rates were calculated using Origin software.  
Acknowledgements 
We thank Dr. William Wickner of antisera. This research was supported by a grant from 
the National Institutes of Health (GM101132) to RAF. MLS was supported by a NIGMS-NIH 











Figure 2.1. Vam7-6A requires higher concentrations to reach Vam7 fusion levels. (A) Schematic representation of Vam7 and its polybasic region. (B) Vacuole fusion 
reactions were performed using vacuoles from BJ3505 and DKY6281. Fusion reactions were incubated with 60 µg/ml α-Sec17 for 10 min on ice followed by addition 
of recombinant wild type Vam7 or Vam7-6A at the indicated concentrations for 5 min on ice. Fusion reactions were incubated at 27°C for 90 min and assayed for 
Pho8 activity. (C) Lipid Mixing (hemifusion) assays were performed using WT vacuoles inhibited with anti-Sec17 IgG at 4°C. Reactions were transferred from ice to 
27°C and incubated for 5 min prior to the addition of ATP regenerating system. After additional 10 min incubation wild type Vam7 or Vam7-6A was added to the 
indicated reactions. An increase in fluorescence occurs when the outer leaflet of vacuoles mix during hemifusion. Shown is a representative of three trials. (D) The 









Figure 2.2. Vam7-6A is unable to rescue to Vam7 levels. Fusion reactions were carried out using WT (A-D) or ycf1Δ vacuoles (E). Fusion reactions were incubated 
with 2 mM propranolol (A), 100 µg/ml PX (B), 347 µg/ml SigD (C), or 95 µg/ml C1b and 150 µM CPZ (D). Fusion reactions were incubated with inhibitor for 10 min on 
ice followed by addition of wild type Vam7 or Vam7-6A at the indicated concentrations for 5 min on ice. Fusion reactions were then incubated at 27°C for 90 min 










Figure 2.3. Vam7-6A shows a decrease in protein-protein interactions. (A) To examine the interactions with other proteins in the SNARE complexes we monitored 
the binding of Vam3, Nyv1 and Vps16 to isolated GST-Vam7 complexes. WT vacuoles were incubated at 27°C for the indicated times in the presence of 150 nM 
Vam7 (WT or 6A). After incubation, reactions were centrifuged to isolate the membrane fraction. Membranes were solubilized, and GST-Vam7 complexes were 
isolated with glutathione Sepharose. Complexes were probed by immunoblotting for GST-Vam7, Vam3, Nyv1 and Vps16. The experiment shown is representative of 
three trials. (B) Quantitation of Vam3 and Nyv1 bound to GST-Vam7. Values represent concentrations relative to time WT Vam7 at time = 0 min. Error bars 








Figure 2.4. Vam7-6A shows a decrease in calcium efflux. (A) Calcium efflux assays were performed using WT BJ3505 vacuoles and contained 150 nM Fluo-4 
dextran. Reactions were transferred to 27°C for incubation and after 1 min ATP or PIPES-Sorbitol buffer was added. After 15 min Vam7 or Vam7-6A was added at 
the indicated concentrations to reactions. Fluorescence was measured for 30 min. A representative experiment of eight repeats is shown. (B) Shown is the average 










Figure 2.5. Vam7-6A shows wild type levels of vacuole association. (A) To examine the recruitment of Vam7-6A we measured the binding isolated vacuoles. 
Vacuoles were incubated with the indicated concentration of either WT GST-Vam7 or GST-Vam7-6A for 10 min. After incubation, vacuoles were centrifuged to 
isolate bound GST-Vam7. Complexes were probed by immunoblotting for Vam3 and Vam7. The experiment shown is representative of 3 trials. (B) Quantitation of 






Figure 2.6. Vam7-6A shows increased binding to PI3P liposomes. To examine the recruitment of Vam7-6A to specific lipids we examined the binding of Vam7-6A to 
liposomes or varying composition. Liposomes were incubated with 150 nM GST-Vam7 (WT or 6A) for 10 min. After incubation, liposomes were centrifuged to isolate 
bound Vam7 by flotation. Liposomes were probed by Western blotting for Vam7. The experiment shown is representative of (3) trials. (A) Liposomes composed of 
PC and PE alone or also containing PI3P, DAG, PA, or PS. (B) Liposomes composes of PC/PE alone or also containing PI, PI4P, or PI5P. (C) Liposomes composes of 
PC/PE alone or also containing PI(3,4)P2, PI(3,5)P2, PI(4,5)P2, or PI(3,4,5)P3. Quantitation of Vam7 bound to liposomes is shown as bar graphs in each panel. Values 
represent concentration compared to Vam7 WT bound to PC/PE liposomes. Error bars represent S.E. (n=3). (D) Liposomes PC/PE alone or with PI3P were incubated 










Table 2.1. Primers for site directed mutagenesis 
Oligonucleotide Sequence  
R164AF 5’ CAGCGTGGCTGGAGCACTAAGGGCACGTACGAAGCTC 3’  
R164AR 5’ GCTCCAGCCACGCTGGGTGTGCCATCACTCTCCTTATC 3’  
R168AF 5’ CACTAGCGGCACGTACGAAGCTCCACAAGTTAC 3’  
R168AR 5’ ACGTGCCGCTAGTGCTCCAGCCACGCTGGG 3’  
R168ARS 5’ ACGTGCCGCTAGTGCTCCACGCACGCTGG 3’  
K172AF 5’ CGTACGGCGCTCCACAAGTTACGAGAGCGACTAG 3’  
K172AR 5’ GGAGCGCCGTACGTGCCGCTAGTGCTCCAG 3’  
K172ARS 5’ GGAGCGCCGTACGTGCAGGTAGTGCTCCAC 3’  
K175AF 5’ TCCACGCGTTACGAGAGCGACTAGAACAGGAT 3’  
K175AR 5’ CGTAACGCGTGGAGCGCCGTACGTGCC 3’  
K175ARS 5’ CGTAACGCGTGGAGCTTCGTACGTGCCCA 3’  
R179AF 5’ CGAGAGGCACTAGAACAGGATGTGCAAAAG 3’  
R179AR 5’ CTAGTGCCTCTCGTAACGCGTGGAGCGC 3’  
R179ARS 5’ CTAGTGCCTCTCGTAACTTGTGGAGCTTCGTA 3’  
K186AF 5’ GTGCAAGCGAAGTCTCTTCCAAGCACGGAAG 3’  
K186AR 5’ GACTTCGCTTGCACATCCTGTTCTAGTGCCTC 3’  
K186ARS 5’ GACTTCGCTTGCACATCCTGTTCTAGTCGCTC 3’  
   
(F) Forward primer. (R) Reverse primer. To make single mutations, the forward (F) primer would be combined with 
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CHAPTER 3: Deleting the DAG Kinase Dgk1 Augments Yeast Vacuole Fusion Through Increased 
Ypt7 Activity and Altered Membrane Fluidity 
ABSTRACT 
Diacylglycerol (DAG) is a fusogenic lipid that can be produced through phospholipase C 
activity on phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2], or through phosphatidic acid (PA) 
phosphatase activity. The fusion of Saccharomyces cerevisiae vacuoles requires DAG, PA and 
PI(4,5)P2, and the production of these lipids is thought to provide temporally specific 
stoichiometries that are critical for each stage of fusion. Furthermore, DAG and PA can be 
interconverted by the DAG kinase Dgk1 and the PA phosphatase Pah1. Previously we found that 
pah1 vacuoles were fragmented, blocked in SNARE priming and showed arrested endosomal 
maturation. In other pathways the effects of deleting PAH1 can be compensated for by 
additionally deleting DGK1, however deleting both genes did not rescue the pah1 vacuolar 
defects. Deleting DGK1 alone caused a marked increase in vacuole fusion that was attributed to 
elevated DAG levels. This was accompanied by a gain in resistance to the inhibitory effects of 
PA as well as inhibitors of Ypt7 activity. Together these data show that Dgk1 function can act as 
a negative regulator of vacuole fusion through the production of PA at the cost of depleting 
DAG and reducing Ypt7 activity.  
__________________________ 
This chapter appeared in its entirety in the journal Traffic and is referred to in this dissertation as 
“Miner, G.E., M.L. Starr, L.R. Hurst, and R.A. Fratti. 2017. “Deleting the DAG Kinase Dgk1 Augments Yeast 
Vacuole Fusion through Increased Ypt7 Activity and Altered Membrane Fluidity.” Traffic 18(5).This 






The movement of vesicles in eukaryotic cells is tightly regulated to prevent the 
missorting of cargo. Each route of membrane trafficking in the endocytic and secretory 
pathways is regulated by homologous sets of proteins that are conserved throughout eukarya. 
The final stage of cargo delivery occurs through the merger of two distinct membranes in a 
fusion reaction catalyzed by SNARE proteins.1 The fusion reaction pathway can be divided into 
stages that start with the disassembly of inactive cis-SNARE bundles. This process, known as 
priming, is executed by the SNARE chaperone NSF/Sec18 and its adaptor protein -
SNAP/Sec17.2 Membranes are subsequently brought into contact by the activity of Rab GTPases 
and their cognate tethering effectors.3 In Saccharomyces cerevisiae, vacuolar lysosomes 
undergo fusion with vesicles from the endocytic pathway, AP-3 coated membranes from the 
Golgi, autophagosomes, as well as with other vacuoles.4–7 Homotypic vacuole fusion requires 
the Rab Ypt7 and its effector complex HOPS for tethering.8,9 During docking, trans-SNARE 
complexes form between partner membranes leading to the release of luminal Ca2+ stores prior 
to fusion.10 Docked vacuoles become tightly apposed forming a flattened region where they are 
in contact that is referred to as the boundary domain. The proteins and lipids that drive fusion 
become enriched at the edge of the boundary termed the vertex ring microdomain.11–13 Fusion 
occurs around the vertex ring leading to the internalization of the boundary membrane and 
degradation of boundary-localized factors. DAG becomes enriched at the both the vertex and 





The regulation of membrane trafficking and fusion also involves a group of signaling 
lipids that play multiple roles in controlling these pathways. Yeast vacuole fusion requires 
diacylglycerol (DAG), phosphatidic acid (PA), as well as multiple phosphoinositides (PI) and 
ergosterol.11,14–20 During the docking stage of fusion, these lipids accumulate into membrane 
microdomains that organize the SNAREs, Ypt7, HOPS and actin at the site of fusion.11,16 The 
stoichiometry of these lipids is not static and requires the function of multiple lipid kinases, 
phosphatases and lipases at different time points to modify lipids to activate (or inactivate) 
their roles at each fusion stage. For instance, the PI 3-kinase Vps34 produces PI3P allowing the 
binding of Mon1, HOPS, and the soluble SNARE Vam7 leading to membrane tethering and 
docking.18,20–23 Similarly, the PA phosphatase Pah1 converts PA to DAG leading to the transfer 
of PA-bound Sec18 to cis-SNARE complexes for priming.19,24  
Pah1 is the yeast Lipin1 orthologue and its activity is required for endoplasmic reticulum 
and nuclear envelope homeostasis as well as lipid drop formation.25,26 In addition, we have 
found that Pah1 activity is required for endosomal maturation. Deletion of Pah1 leads to the 
exclusion of Vps34, Mon1, Ypt7 and Vps39 from vacuolar membranes causing vacuole 
fragmentation and abolished fusion.18,19 Others have shown that the activity of Pah1 can be 
countered by the DAG kinase of Dgk1 to replenish PA.27,28 The morphological defect of the 
endoplasmic reticulum and nuclear envelope seen in pah1 cells is reversed by the 




organelle homeostasis. DAG produced by Pah1 is used for the synthesis of triacylglycerol and 
the formation of lipid droplets as well as feeding into the Kennedy pathway for the production 
of phosphatidylethanolamine and phosphatidylcholine.25,29,30 DAG is a fusogenic lipid due to the 
induction of negative curvature and destabilization of lipid bilayers.31,32 The fusogenicity of DAG 
is further demonstrated by its ability to promote the fusion of protein-free liposomes.33,34 These 
features are linked to its requirement for efficient vacuole fusion.  
In this study we examined the role of Dgk1 in vacuole fusion. We first determined that 
deleting DGK1 in pah1 background strains did not restore the blocked endosomal maturation, 
fusogenicity, or the vacuole fragmentation phenotype caused by deleting PAH1 alone. This 
indicates that Pah1 and Dgk1 functions are not concurrent in vacuole homeostasis unlike their 
offsetting activities in other pathways. Importantly, the single dgk1 mutation led to an 
augmented fusion phenotype. We focused on finding the mechanism for the increased fusion 
of dgk1 vacuoles. These vacuoles contained elevated levels of the fusogenic lipid DAG and 
displayed an enhanced fusion phenotype. This was further characterized with increased 
resistance to the inhibitory effects of PA and elevated Ypt7-mediated vesicle tethering.  
RESULTS 
Vacuole morphology and Dgk1 localization 
Vacuole fusion requires the production and turnover of numerous signaling lipids 




these lipids. DAG can be produced by the activity of Plc1 on PI(4,5)P2 
35 or Pah1 on PA 26. PA can 
be produced by phospholipase D activity on PC or by Dgk1 on DAG.27,36 The production of DAG 
during vacuole fusion is important due to its fusogenic properties.37,38 DAG becomes enriched 
at the vertex ring and boundary membrane of docked vacuoles and regulates localization of 
SNAREs, Ypt7 and HOPS to the site of fusion.  
We previously found that deletion or inactivation of PAH1 inhibited endosomal 
maturation that was characterized by vacuoles that lacked the late endosomal/lysosomal Rab 
Ypt7, the HOPS subunit Vps39, as well as the PI 3-kinase Vps34 and its product PI3P.19 The lack 
of Ypt7 was due to the exclusion of its guanine exchange factor Mon1-Ccz1, which is recruited 
to membranes in part through its interactions with PI3P.18,21 Because deletion of DGK1 restores 
the effects of deleting PAH1 in other pathways we began by testing whether the double 
deletion would restore the pah1 vacuolar defects. We first examined whether the double 
deletion would restore pah1 vacuole morphology. We found that dgk1 cells exhibited wild 
type vacuole morphology (Fig. 1A). Curiously, the dgk1 pah1 double deletion cells were 
fragmented in a manner similar to pah1 cells. Thus, deleting both enzymes did not rescue the 
pah1 vacuole fragmentation phenotype or blocked fusion. This was not in keeping with the 
effects seen in restoring nuclear/endoplasmic reticulum morphology in other pathways. 
Quantitation of vacuole fragmentation is shown in Figure 1B.  
Due to the lack of an effect of deleting DGK1 on the pah1 vacuole morphology 




distribution of Dgk1-GFP in wild type whole cells. Figure 1C shows widefield fluorescent images 
showing Dgk1-GFP localization in cells stained with FM4-64 to label vacuoles. Dgk1-GFP 
localized to ribbon-like structures of the endoplasmic reticulum similar to what has been 
previously reported.39 We also observed that the Dgk1-GFP ribbons were often adjacent to 
vacuoles and a fraction of Dgk1-GFP colocalized with FM4-64 suggesting that aside from the 
endoplasmic reticulum, vacuoles also harbor a portion of the enzyme. Dgk1-GFP localization 
was next examined in pah1 cells and we did not detect any appreciable differences in it 
localization relative to the wild type parent strain. Because some Dgk1-GFP appeared to 
colocalize with vacuoles we further examined Dgk1 distribution by cell fractionation and 
immunoblotting. Yeast cells expressing Dgk1-HA were fractionated into crude lysate, cytosol, 
vacuoles, a total membrane pool as well as microsomes containing endoplasmic reticulum. The 
blots showed that Dgk1-HA was present in microsomes and vacuoles (Fig. 1D). As a control, we 
probed for Dgk1-HA in the cytosolic fraction and found that this polytopic protein was absent. 
Ypt7 served as an enrichment marker for vacuoles. Sec61 served as a marker for resident 
endoplasmic reticulum components. Sec61 was detected in the vacuole fraction indicating that 
there was some contamination from the endoplasmic reticulum. Although this accounts for the 
majority of the Dgk1 detected in the vacuole fraction, it should also be noted that the ratio of 
Dgk1 to Sec61 is greater on vacuoles relative to the microsome fraction (Fig. 1E). Together with 
the Dgk1-GFP localization it is apparent that a subpopulation of Dgk1 does indeed reside on the 
vacuolar membrane.   




To determine if deleting DGK1 would have an effect on vacuolar DAG levels we 
quantitated this lipid on vacuoles from wild type and dgk1 cells. Neutral lipids were extracted 
from wild type and dgk1 vacuoles and resolved by thin-layer chromatography as described in 
the Materials and Methods section. Purified DAG was used to generate a standard curve in the 
first six lanes of the plate (Fig. 2A). Three of the five trials run were loaded onto the plate 
shown. We found that dgk1 vacuoles consistently contained more DAG than wild type 
vacuoles. Figure 2B shows quantitation of five trials (p<0.05). The DAG content of wild type and 
dgk1 vacuoles was calculated using a standard curve of pure DAG and plotted as g of DAG 
per 150 g of vacuole protein. These data indicate that vacuoles will accumulate DAG in the 
absence of Dgk1. However, this does not indicate whether the difference in DAG content is due 
to Dgk1 activity on the vacuole or whether the lack of DAG kinase activity elsewhere affects the 
total amount of this lipid trafficked to vacuoles.  
The absence of Dgk1 augments vacuole fusion  
To further examine the consequence of deleting DGK1 on vacuole homeostasis we tested 
fusion efficiency. These experiments showed that dgk1 vacuole fusion was markedly increased 
by ~40% relative to wild type (Fig. 3A), suggesting that the conversion of DAG to PA by Dgk1 
negatively regulates fusion. This is in keeping with the notion that DAG is fusogenic and that 
Dgk1 activity is needed to reduce unchecked fusion. We next asked if the rate of fusion itself 
was increased for dgk1 vacuoles. The slope of the fusion curve for dgk1 vacuoles appeared 




normalizing fusion to the wild type maximum. While this shows the overall increase in total 
fusion, it does not clearly show the initial rate of fusion. To better visualize the rate of dgk1 
vacuole fusion we re-plotted the data as normalized to its own maximal fusion at the end of 90 
min (Fig. 3A, red circles). This approach showed that the adjusted dgk1 fusion curve perfectly 
overlapped with that of wild type vacuoles, indicating that the rates of fusion were identical 
and that the augmented fusion of dgk1 vacuoles was due to other factors. We also asked 
whether the augmented fusion occurred during different rounds of fusion. To this aim we used 
a method shown to differentiate the first round of fusion from later events.40 Previously we 
used this method to determine that deleting NHX1 only affected the first round of fusion 
without affecting subsequent fusion cycles.41 To detect the first round of fusion, a 5:1 excess of 
effector vacuoles (PEP4 pho8) was used. For later rounds of fusion reactions used a 4:2 excess 
of reporter vacuoles (pep4 PHO8). Using this method we found that dgk1 vacuoles showed 
enhanced fusion for both early and late rounds of fusion (Fig. 3B), suggesting that the effects of 
deleting DGK1 was consistent.  
Although we have shown that the rate of full fusion and content mixing of dgk1 
vacuoles matches that of wild type, it was possible that the elevated levels of DAG could 
destabilize the bilayers enough to promote faster hemifusion. Thus, we next measured the 
mixing of outer leaflet lipids as a reporter for hemifusion.16,42 Here, a population of vacuoles is 
loaded with rhodamine conjugated PE (Rh-PE) at levels that quench fluorescence. Rh-PE labeled 
vacuoles are then incubated with an 8-fold excess of unlabeled vacuoles. Upon lipid mixing of 




approach showed that dgk1 vacuoles underwent lipid mixing at the same rate versus wild 
type (Fig. 3C). Also shown are the negative controls of excluding ATP or blocking priming with 
anti-Sec17 antibody. These data suggest that the fusion phenotype of dgk1 vacuoles was not 
due to an increased rate of fusion of a set amount of vacuoles but perhaps is a refection that 
more vacuoles are initially participating in fusion.   
Because changes in fusion, as a measure of Pho8 activity, could theoretically be affected 
indirectly by altered activity of the reporter enzyme itself, we verified that the increased fusion 
of dgk1 vacuoles was real by performing a visual assay to measure changes in vacuole 
diameter.40,43 Here, vacuole reactions were treated with buffer, anti-Sec18 IgG or propranolol. 
Both inhibitors potently inhibit fusion at the priming stage.2,19 Propranolol is a -adrenergic 
receptor blocker that also inhibits PA phosphatase activity, which is required for Sec18-
mediated SNARE priming to occur.24,44 After incubation (90 min, 27C), fusion reactions were 
placed on ice and stained with FM4-64 for fluorescence microscopy evaluation. In accord with 
the content mixing assay, we found that the diameters of dgk1 vacuoles were significantly 
larger relative to wild type vacuoles (Fig. 3D, p<0.05). Incubating reactions on ice as well as 
treatment with anti-Sec18 or propranolol blocked the increase in vacuole diameter 
demonstrating that changes in vacuole size were due to fusion.  
To determine whether the kinase activity of Dgk1 was linked to the fusion 
enhancement, dgk1 strains were complemented with plasmids encoding either wild type DGK 




fusion to near wild type levels (Fig. 3E). The lack of full wild type fusion restoration with 
complementation was thought to be due to plasmid loss during growth in non-selective 
medium for vacuole purification. Nevertheless, the difference in fusion between the dgk1 and 
complemented vacuoles was statistically significant (p<0.05). Moreover, the difference 
between wild type fusion and the complement was not significant (p=0.25). Complementation 
with the kinase-dead mutant pDGKD177A did not reverse the increased fusion seen with dgk1 
vacuoles (Fig. 3F). These data demonstrate that the altered fusion seen with dgk1 vacuoles 
was directly due to the kinase activity of Dgk1.  
In Figure 1A-B we showed that the dgk1 pah1 double deletion did not restore the 
vacuole fragmentation phenotype of pah1 alone. To further verify effect of deleting DGK1 on 
pah1 vacuole function we tested the mutations in content mixing assays. We found that the 
dgk1 pah1 double deletion strains exhibited attenuated fusion similar to what occurs with 
the single PAH1 deletion (Fig. 3G). As with the morphological examination of the double 
deletion strain, we concluded that the activities of these enzymes do not directly 
counterbalance each other with respect to vacuole homeostasis and fusion. For this reason we 
focused on the augmented fusion of dgk1 vacuoles for the remainder of the study. 
Changes in fusion could be attributed to a variety of factors including changes in the 
concentration of regulatory proteins such as SNAREs. Others have shown that increased SNARE 
levels can enhance vacuole fusion.45 Deletion of the ABC transporter Ybt1 and the casein kinase 




assess if the elevated fusion of dgk1 vacuoles was due to changes in the fusion machinery we 
performed immunoblotting analysis of known regulators. No differences were observed 
between dgk1 vacuoles and wild type (Fig. 3H). Taken together we conclude that Dgk1 activity 
suppresses maximal vacuole fusion and that the increased fusion seen with dgk1 vacuoles was 
not due to a fault in the reporter systems or caused by increased levels of the core fusion 
machinery proteins. 
DGK1 deletion does not alter SNARE complex formation 
Vacuole fusion can be augmented by the increase in the copies of SNAREs or by the 
improved efficiency of complex formation.16,45 As seen in Figure 3H, the amount of individual 
SNAREs was unaffected by deleting DGK1, however, their effectiveness is not apparent by 
immunoblotting alone. Thus we examined the efficiency of SNARE complex formation. This 
assay relies on blocking priming with anti-Sec17 IgG and its bypass by the addition of 
recombinant GST-Vam7 to restore fusion.47,48 First, we determined if the dosage required for 
the bypass was different for dgk1 vacuoles relative to wild type. Figure 4A shows the 
restoration of fusion upon addition of GST-Vam7 at the indicated concentrations. This showed 
that dgk1 vacuoles responded to the addition of GST-Vam7 at the same peak of efficacy 
compared to wild type.  
Next, we performed Vam7 bypass experiments to examine the formation of SNARE 
complexes and HOPS binding. We found that GST-Vam7 interacted with its cognate SNAREs 




it appears that the altered fusion seen with dgk1 vacuoles was not due to increased SNARE 
complex formation. To verify that SNARE complexes were similarly active on both vacuole types 
we examined the efflux of luminal Ca2+ stores that are released upon trans-SNARE complex 
formation.10 Previously we have found that deletion of the ABC transporter Ybt1 strikingly 
delayed the kinetics of Ca2+ efflux, which was linked to increased vacuole fusion.43 However, 
there was no difference in the kinetics or amplitude of Ca2+ release between dgk1 and wild 
type vacuoles (Fig. 4D). Together these data indicated that increased fusion of dgk1 vacuoles 
was not directly due to altered SNARE complex formation.  
Deletion of DGK1 confers resistance to PA  
Previous studies showed that reducing, or blocking, DAG inhibited the enrichment of 
regulatory lipids at the vertex ring assembly and blocked fusion.11,15 We next asked if increasing 
DAG levels through the deletion of DGK1 would alter the role of regulatory lipids in fusion. To 
this aim we examined the effects of blocking regulatory signaling lipids on dgk1 vacuoles. We 
found that blocking the function of PI3P, PI4P, PI(4,5)P2, and ergosterol with the ligands FYVE, 
FappPH, ENTH, and filipin respectively inhibited dgk1 vacuole fusion indistinguishably from 
wild type (Fig. 5A). There was also no difference when PI3P and PI(4,5)P2 were modified by the 
phosphatases MTM-1 and SigD, respectively. This indicated that the enhanced fusion 
phenotype was not due to additional changes in the core fusion machinery or due to off 
pathway mechanisms. Because Dgk1 activity altered DAG levels on isolated vacuoles we next 




dgk1 vacuole fusion at the same concentration needed to block wild type fusion (Fig. 5B). This 
suggests that the change in DAG does not directly affect a protein-lipid interaction such as the 
binding of Protein kinase C (PKC) to DAG on other membranes.49 Instead it is likely that the 
augmented fusion is a result of an indirect effect such as changes in membrane curvature and 
fluidity. It is also possible that a population of DAG was inaccessible to C1b by accumulating in 
the boundary membrane or by translocating across the bilayer.11,50  
As is now evident, the conversion of PA to DAG by Pah1 is necessary for vacuolar SNARE 
priming.24 Increasing PA concentrations through inactivation of Pah1 or through the addition of 
short-chain PA (diC8-PA) potently blocked fusion by sequestering Sec18 away from SNAREs in a 
PA-dependent manner. Thus, we asked if the increase in DAG on dgk1 vacuoles would shift 
the DAG:PA ratio in a way that would alter the sensitivity of fusion towards PA. To answer this 
we tested the effect of converting DAG to PA with recombinant His6-DgkB, the soluble DAG 
kinase from Staphylococcus aureus.51 We found that DgkB potently inhibited wild type vacuole 
fusion as well as fusion by dgk1 vacuoles (Fig. 5C). However, there was a right-shift in the 
inhibition curves for dgk1 vacuole fusion that was statistically significant at 130 and 220 µg/ml 
(p<0.05). Although the shift was not large it was consistent with needing more DgkB for the 
elevated level of DAG at the beginning of the reaction.  
To further test the effects of increasing PA on fusion we added diC8-PA to fusion assays. 
As previously shown, the addition of diC8-PA had a marked inhibitory effect on the fusion of 




with dgk1 vacuoles. The IC50 of diC8-PA on wild type vacuoles was 31.2±5.1 µM whereas the 
IC50 was 122.8±15.2 µM for dgk1 vacuoles (*p<0.05). The increased resistance of dgk1 
vacuole fusion to diC8-PA suggests that the elevated levels of DAG lead to a requirement of 
more diC8-PA to fully inhibit fusion. Together these data indicate that the ratio of DAG to PA is 
a critical component of regulating vacuole fusion.  
Augmented dgk1 vacuole fusion is linked to enhanced Ypt7 activity 
To test if the augmented fusion of dgk1 vacuoles was on pathway and regulated by the 
known machinery, we tested a panel of inhibitors that targeted the proteins that regulate 
vacuole fusion. Figure 6A shows that antibodies against the SNAREs Nyv1, Vam3, or the HOPS 
subunit Vps33 inhibited dgk1 vacuole fusion with similar effects compared to wild type. The 
relative fusion endpoints for both wild type and dgk1 vacuoles were normalized to 100% (Fig. 
6A). Interestingly, dgk1 vacuole fusion showed reduced sensitivity to anti-Ypt7 IgG. To further 
examine the change in sensitivity of dgk1 vacuoles to anti-Ypt7 we performed dose response 
assays to calculate the IC50. This showed that dgk1 fusion was significantly less sensitive to 
anti-Ypt7 with an IC50 of 124.9±10.7 µg/ml while the IC50 for wild type was 61.2±8.1 µg/ml (Fig. 
6B, *p<0.05). This suggests that Ypt7 could be more active in dgk1 vacuoles. It is also possible 
that changes in the membrane curvature and fluidity could allosterically induce conformational 
changes in Ypt7 leading to decreased binding by the antibody. Based on the effects of anti-Ypt7 
IgG we also examined the efficacy of the GTPase activating protein Gyp1 and the Rab-GDP 




dgk1∆ vacuole fusion. Figure 6C shows that dgk1∆ vacuole were less sensitive to Gyp1-46 with 
an IC50 of 2.17±0.06 M compared to wild type (IC50 = 1.54±0.046 M, *p<0.05). Similarly, 
dgk1∆ vacuole fusion was more resistant to GDI versus wild type. The IC50 for GDI with dgk1∆ 
vacuoles was 112.7±8.7 nM, while the IC50 with wild type was 209.2±14.1 nM (Fig. 6D, *p<0.05). 
Together these data suggest that Ypt7 function is enhanced in dgk1∆ vacuoles. That said, these 
assays do not distinguish whether dgk1 vacuoles have increased activity per individual Ypt7 
molecule or if there are simply more numerous activated Ypt7 copies per vacuole. Alternatively, 
it is possible the dgk1 require less Ypt7 to promote fusion.   
The dgk1 fusion effect is in parallel to the function of Yck3 
In addition to the effect of deleting DGK1 on Ypt7 function shown here, Ungermann et 
al. found that deleting the type I casein kinase Yck3 resulted in fusion that was resistant to Gdi1 
and Gyp7-47.52 This was linked to augmented vacuole fusion. Yck3 activity reduces fusion by 
phosphorylating Vps41, Vam3 and Mon1.18,52,53 The similar phenotypes of elevated fusion and 
increased Ypt7 activity in both yck3 and dgk1 vacuoles led us to ask if they shared a common 
pathway. We previously reported that the Ypt7 GEF Mon1-Ccz1 was phosphorylated by the 
casein kinase Yck3 leading to its release from the membrane.18 Deletion of YCK3 or mutation of 
Mon1 phosphorylation sites prevented Mon1 from being released from the membrane during 
fusion. The influence of Yck3 on fusion is further illustrated through the inhibitory activity of 
adding exogenous recombinant His6-Yck3.
46 Together, the data suggest that Dgk1 and Yck3 lie 




The experiments in Figure 7 begin addressing the connection between Dgk1 and Yck3. 
First, we immunoblotted for Yck3 on wild type and dgk1 vacuoles and found that the kinase 
was present at equal levels on membranes from both strains (Fig. 7A-B). This shows that Yck3 
does not require Dgk1 for its recruitment to vacuoles. Next we examined if Yck3-dependent 
Mon1 release occurred on dgk1 vacuoles. Figure 7C shows that Mon1 was released at the 
same rate on both sets of vacuoles, indicating that Yck3 function was normal on dgk1 
membranes. Figure 7D shows quantitation of Mon1 retention over time. Although Mon1 
release was not affected on dgk1 we went on to test if the addition of recombinant Yck3 
would differentially affect the two types of vacuoles. We found that added His6-Yck3 inhibited 
the fusion of wild type and dgk1 vacuoles with identical dose responses (Fig. 7E). Thus far, it 
appears that Yck3 and Dgk1 functions are likely in parallel pathways. To further determine if the 
underlying mechanisms of the dgk1 and yck3 fusion phenotypes are linked, we constructed 
yck3 dgk1 double deletion strains. We hypothesized that if the two functions were in parallel 
we would observed additive increases in vacuole fusion relative to either yck3 or dgk1 single 
deletions. The lack of further augmented fusion would suggest that the Dgk1 and Yck3 
pathways overlap. We found that both yck3 and dgk1 single deletions had enhanced fusion 
as seen previously. Unexpectedly, the double yck3 dgk1 double deletion fused to a similar 
extent the wild type parent strains (Fig. 7F, p>0.05). The loss of augmented fusion suggests that 
Yck3 and Dgk1 function in different pathways. Although evidence is lacking, it is not unlikely 
that the altered function of Ypt7 due to the lack of Dgk1 was negatively affected by the 




overall function. That said, further studies would be required to explore this possibility, which 
go beyond the scope of this study.  
Exogenously added DAG enhances fusion of wild type vacuoles 
Because dgk1∆ vacuoles contain increased levels of DAG, we next asked if adding the 
lipid exogenously to wild type vacuoles would alter fusion. Previously we found that while 
vacuole fusion was inhibited with short chain phosphatidic acid (diC8-PA), fusion was not 
affected by diC8-DAG.24 The effect of diC8-PA was attributed to the interaction of the PA 
headgroup with Sec18 to prevent SNARE priming. DAG on the other hand is directly fusogenic 
and transmits its effects on membranes through its acyl chains. Thus, the lack of an effect by 
diC8-DAG was attributed to the inability of short acyl chains to influence membrane curvature 
or bilayer stability. To better determine the effect of exogenous addition of this lipid we used 
long chain (16:0, 18:1) DAG to wild type and dgk1∆ vacuole fusion reactions. We found that 
adding DAG enhanced the fusion wild type vacuoles by ~17% at 5 nM while it had no effect on 
dgk1∆ vacuoles (Fig. 8A, *p<0.05). Higher levels of DAG did not further enhance fusion (not 
shown). Although the addition of DAG did not fully mimic the effect of deleting DGK1, it does 
support the notion that DAG levels alone can modulate the efficacy of fusion. Similarly, the 
addition of 5 nM DAG increased lipid mixing by approximately 20% (Fig. 8B, **p<0.01).  




In previous studies we found that mutating the ionic zero layer of the Vam7 SNARE 
motif (Q283R) prevented anti-Sec17 bypass fusion.48,54 Fusion reactions containing Vam7Q283R 
were arrested at a hemifusion intermediate. Fusion could be restored by altering the fluidity 
and curvature of the vacuole with the cationic amphiphile chlorpromazine. We hypothesized 
that mutant SNARE complexes containing Vam7Q283R transferred insufficient energy to the 
membrane to trigger fusion. Thus, the effect of chlorpromazine was thought to be due to 
lowering the energy barrier for fusion to a level where Vam7Q283R could function. Due to the 
increased DAG concentration in dgk1 vacuoles we asked if fluidity and curvature was 
sufficiently altered to promote Vam7Q283R mediated fusion. Fusion reactions blocked with anti-
Sec17 IgG were treated with recombinant Vam7Q283R at the indicated concentrations. We found 
that Vam7Q283R was able to promote a modest level of fusion in dgk1 vacuoles whereas wild 
type vacuole fusion were unresponsive (Fig. 8C, **p<0.01). This result is consistent with the 
notion that the increase in DAG on dgk1 lowers the energy barrier for fusion in a similar 
manner to what was seen with chlorpromazine. It is important to consider that exogenous 
Vam7 rescues anti-Sec17 blocked fusion also bypasses the role of Ypt7 dependent tethering, 
which requires Sec17 mediated SNARE priming. Thus, the enhanced Ypt7 activity likely did not 
play a role in this experiment.  
DISCUSSION 
It has been well established that most membrane fusion is catalyzed by SNARE proteins, 




Among the lipids that compose the membrane is a group that is subject to modification by 
specific kinases, phosphatases, and lipases to regulate membrane trafficking. The most studied 
of these lipids are the phosphoinositides that can be differentially phosphorylated on their 
inositol head groups to yield a panel of bioactive molecules that help orchestrate the fusion 
machinery through direct interactions with protein ligands. Specific PIs are necessary at various 
stages of fusion. For instance, vacuole fusion requires PI(4,5)P2 during priming as well as after 
docking.55,56 PI(4,5)P2 is turned over by Plc1 to yield IP3 and DAG, a fusogenic lipid required for 
vacuole content mixing.15 DAG can also be produced through the activity of the PA phosphatase 
Pah1, a pathway that is complemented by the activity of Dgk1 on DAG to restore PA levels.28,57 
PA plays important roles in various membrane trafficking pathways including sporulation, 
mitochondrial fusion, and Glut4 trafficking.58–60 Like DAG, PA induces negative curvature.61 
However the monophosphoester head group of PA adds a negative charge to the membrane 
that can play a role in binding proteins, including NSF/Sec18.24,62 Moreover, Pah1 activity is 
required during Sec18-mediated priming.19,24 Deletion of Pah1 leads to broad cellular defects 
including the enlargement of the endoplasmic reticulum and nuclear membranes, blocked lipid 
droplet synthesis, and inhibited endosomal maturation.18,19,25,26  
In other pathways, such as lipid droplet formation, the effects caused by deleting PAH1 
can be countered by concurrent deletion of DGK1 illustrating that the interconversion of PA and 
DAG by Pah1 and Dgk1 respectively can negate the effects of inactivating one of the 
enzymes.25,27 Importantly, it shows that the balance struck by these two enzymes is consistent 




on the pah1 vacuolar phenotype (Fig. 9). This suggested one of two things. First, it is likely that 
the defect seen in pah1 vacuoles was not simply due to a steady-state imbalance of PA and 
DAG. It is possible that the PA:DAG ratio varies throughout the fusion pathway. For example, 
Pah1 activity is needed during priming, indicating that a reduction of PA and increase in DAG is 
necessary.19 However, inhibiting Pah1 activity after priming has no effect on fusion, 
demonstrating that PA levels no longer need to be reduced. Our previous findings show that 
DAG does not play a role during priming but is instead required after the formation of trans-
SNARE complexes.15,16,47,48 This leads us to propose that the activities of Dgk1 and Pah1 are 
separated temporally on the fusion pathway making it unlikely to balance activities at any time. 
A second possibility is that DAG generated by Pah1 is fed into lipid synthesis pathways to 
generate phosphatidylethanolamine and phosphatidylcholine through the Kennedy pathway, or 
into the formation of triacylglycerol for storage.25,63 However, the latter is unlikely as lipid 
synthesis occurs at the endoplasmic reticulum and not the vacuole. Nevertheless, changes in 
lipid synthesis can propagate throughout the cell via membrane trafficking.  
Although both PA and DAG are essential for vacuole fusion, their exact function remains 
to be fully elucidated. DAG is a fusogenic lipid due in part to its intrinsic negative curvature in a 
membrane and ability to destabilize lipid bilayers and even trigger the fusion of protein-free 
vesicles.31–34 DAG can also bind fusion regulators such as protein kinase C (PKC) through its C1 
domain.64,65 PKC has been shown to affect membrane fusion by several pathways including the 




Syntaxin4 to control thrombin release from platelets.62,66 That said, it has not been determined 
whether PKC activity occurs on isolated vacuoles. 
Another potential reason for the enhanced fusion of dgk1 vacuoles is that skewing the 
lipid balance to have less PA versus DAG can have an effect on priming. In a separate study we 
found that PA binds Sec18 to prevent cis-SNARE complex association.24 Conversion of PA to 
DAG by Pah1 releases Sec18 allowing it to engage cis-SNARE bundles. An excess of PA or 
inhibiting Pah1 activity results in the retention of Sec18 on PA domains. Thus we theorized that 
the converse could occur in the absence of Dgk1 and a likely reduced pool of PA would facilitate 
the recruitment of Sec18 to cis-SNARE complexes and lead to more efficient priming. Enhanced 
priming could result in a functional increase in active SNAREs and would be in keeping with 
other studies showing that overexpression of SNAREs augments vacuole fusion. In our hands 
however, we did not observe a difference in priming activity on dgk1 vacuoles (not shown). 
Thus, we conclude that the effects of deleting DGK1 are mostly due to the physical changes 
caused by elevated DAG. This notion is consistent with bilayer destabilization by the non-
lamellar lipid DAG and lowering the energy barrier needed for SNAREs to trigger fusion.  
One of the striking findings of this study was that fusion showed decreased sensitivity to 
reagents that target Ypt7 activity. Our results showed that fusion gained varying levels of 
resistance to anti-Ypt7 antibody, the GAP Gyp1-46, and GDI. One interpretation of these results 
is that Ypt7 is more active on dgk1 vacuoles and that increased activity would manifest in 




light microscopy, we propose a model where the lipid composition of the vacuole modulates 
Rab activity. Alternatively, these results could reflect a reduced need of Ypt7 for dgk1 vacuole 
fusion.   
How would an increase in DAG levels affect Ypt7 function? To date there is no direct 
evidence of membrane fluidity affecting Rab proteins. One can imagine that the membrane 
affects the rotation or angle of insertion of the Ypt7 lipid anchor leading to an altered 
conformational state that strengthens its interactions with the HOPS complex, or a yet to be 
identified binding partner. Alternatively, the increase in DAG could lead to the enhanced 
recruitment of a Rab interacting protein. For example, in mammalian renal cortical tubule and 
mesangial cells the production of DAG promotes the interactions of hmunc13 with Rab34.67 
This was due to the DAG recruitment of hmunc13 to membranes containing Rab34. The latter is 
unlikely here as the IC50 of C1b was unaltered on dgk1 vacuoles, suggesting that there was no 
change in competition for a protein ligand. Therefore, we favor a model where the physical 
properties of the membrane modulate Ypt7 activity. Although evidence linking Rab activity to 
the physical properties of a membrane is lacking, there are some clues that come from 
cholesterol storage defects. For instance, cholesterol accumulation prevents the mammalian 
Ypt7 homologue Rab7 from recruiting its effector protein RILP.68 This is linked with the 
inhibition of fusion between lysosomes and phagosomes and is likely due to decreased 
membrane fluidity caused by the increase in cholesterol as seen Niemann-Pick type C disease 
cells.69 Decreased fluidity due to excess cholesterol in Niemann-Pick type C disease cells has 




the conclusion cholesterol plays a role in the Rab7 cycle. These studies are in keeping with our 
proposed model where membrane fluidity modulates Rab activity. 
In summary, our observations indicate that the PA-to-DAG ratio, regulated in part by the 
non-concurrent, yet complementary functions of Pah1 and Dgk1, can modulate vacuole fusion. 
The effects of increased DAG in the absence of Dgk1 led to improved Ypt7 activity as shown by 
the increased resistance to Gyp1-46, GDI and anti-Ypt7 antibody. Finally, the changes in the 
physical properties of dgk1 vacuole membranes restored the ability of Vam7Q283R to stimulate 
fusion.  
MATERIALS AND METHODS 
Reagents  
Reagents were dissolved in PS buffer (20 mM PIPES-KOH, pH 6.8, 200 mM sorbitol). 
Recombinant GST-FYVE 71, His6-MTM-1 
72, GST-C1b 65, His6-SigD 
73, GST-ENTH 74, MBP-FAPP1-PH 
75, His6-DgkB 
51, GST-Vam7 and GST-Vam7Q283R 48, Gdi1 45, His6-Gyp1-46 
76, His6-Yck3 
46 and Pbi2 
77 were prepared as described and stored in PS buffer with 125 mM KCl. The plasmid for 
expressing His6-DgkB was a gift from Dr. C. Rock (St. Jude Children’s Research Hospital, 
Memphis, TN). Antibodies against Sec17 2, Sec18 78, Vam3 79, Nyv1 80, Vps33 9, Ypt7 8 were 
prepared as described. diC8-PA (1,2-dioctanoyl-sn-glycero-3-phosphate), diC8-DAG (1,2-diC8-




Lipids as chloroform stock solutions and stored at -20ºC. Filipin III was dissolved in DMSO at a 
stock concentration of 10 mM. Propranolol (Sigma) was dissolved in PS buffer.  
Strains  
Vacuoles from BJ3505 and DKY6281 were used for fusion assays (Table 1).81 Strains 
lacking PAH1 or YCK3 were described previously.19,82 DGK1 was deleted by homologous 
recombination using PCR products amplified using 5’-DGK1-KO and 3’-DGK1-KO primers with 
homology flanking the DGK1 coding sequence (Table 2). The PCR product was transformed into 
yeast by standard lithium acetate methods and plated on YPD media containing G418 (250 
µg/µl) to generate BJ3505 dgk1::kanMX6 (RFY60) and DKY6281 dgk1::kanMX6 (RFY61). 
DGK1 was deleted from pah1 strains using PCR products amplified from pFA6A-hphMX4 and 
plated on YPD media containing hygromycin to generate RFY62 and RFY63. For 
complementation of dgk1, RFY60 and RFY61 were transformed with pRS416 plasmids 
encoding DGK1 or DGK1D177A inserted between the EcoRI and NotI sites to generate RFY64-67. 
The DGK1 open reading frame was cloned using 5’-DGK1 and 3’-DGK1 primers using genomic 
DNA as a template. Point mutations generated using 5’-DGK1D177A and 3’-DGK1D177A primers. 
Transformants were selected on complete synthetic media lacking uracil. For cellular 
distribution analysis, DGK1 was fused in frame to GFP. DKY6281 was transformed with a PCR 
product amplified from pFA6a-GFP(S65T)-KanMX6 with homology flanking the stop codon of 
DGK1 with 5’-DGK-GFP and 3’DGK-GFP primers. Transformants were plated on YPD medium 




amplified with 5’-PAH1-KO and 3’-PAH1-KO primers from pAG32 with homology flanking the 
PAH1 coding sequence to generate RFY71. For immunoblotting DGK1 was fused in frame to 
HA3. BJ3505 was transformed with a PCR products amplified from pFA6a-3HA-kanMX6 with 
homology flanking the stop codon to generate RFY69.84 Using the 5’-YCK3-KO and 3’-YCK3-KO 
primers YCK3 was deleted from dgk1 strains to generate RFY72-73. 
Vacuole isolation, cell fractionation, and in vitro vacuole fusion  
Vacuoles were isolated as described.81 In vitro fusion reactions (30 µl) contained 3 µg 
each of vacuoles from BJ3505 and DKY6281 backgrounds, reaction buffer (20 mM PIPES-KOH 
pH 6.8, 200 mM sorbitol, 125 mM KCl, 5 mM MgCl2), ATP regenerating system (1 mM ATP, 0.1 
mg/ml creatine kinase, 29 mM creatine phosphate), 10 µM CoA, and 283 nM Pbi2 (Protease B 
inhibitor). Reactions were incubated at 27C and Pho8 activity was assayed in 250 mM Tris-Cl, 
pH 8.5, 0.4% Triton X-100, 10 mM MgCl2, 1 mM p-nitrophenylphosphate. Fusion units were 
measured by determining the p-nitrophenolate produced and absorbance was detected at 400 
nm.  
For Dgk1 localization by immunoblotting, yeast cells were fractionated into a total 
lysate, a total endomembrane fraction (Membranes), cytosol, endoplasmic reticulum 
(microsomes), and vacuoles as previously described.41,85 For the total membrane preparation, 
yeast cells were resuspended in bead buffer (10 mM Tris/HCl, pH 7.4, 0.3 M sorbitol, 0.1 M 
NaCl, 5 mM MgCl2) containing 1 mM PMSF at a density of 200 A600 units/ml. Cells were 




Lysates were centrifuged in a table-top centrifuge at 100 g for 5 min to pellet large debris and 
the supernatants carefully withdrawn and transferred to ultracentrifuge tubes. The total 
membrane fraction was collected by centrifugation (100,000 g, 1 h, 4°C) and resuspended in PS 
buffer (20 mM PIPES-KOH, pH 6.8, 200 mM sorbitol). The supernatant was saved as the 
cytosolic fraction. Endoplasmic reticulum derived microsomes were prepared as described.86 
Briefly, yeast cells were treated with lyticase to produce spheroplasts as performed for vacuole 
preparations. Spheroplasts were resuspended in buffer (5 mM MES, pH 5.0, 0.5 mM EDTA, 0.6 
M sorbitol, 1 mM PMSF) and centrifuged (20,000 g, 0.5 h, 4°C) using a JA-20 rotor. Supernatants 
were collected and microsomes were pelleted by centrifugation (SW-41 rotor, 60,000 g, 0.5 h, 
4°C). The pellet was resuspended in 100 µl of buffer.  
Quantification of Vacuolar Diacylglycerol by Thin-Layer Chromatography 
Lipids were extracted from purified DKY6281 and dgk1∆ vacuoles (200 µg protein 
content) by the method of Bligh and Dyer then dried overnight under vacuum.87 Purified lipids 
were resuspended in chloroform:methanol (2:1) before being resolved by neutral lipid thin-
layer chromatography as previously described.88 Briefly, Whatman Partisil® LK6D Silica Gel 
Plates (60 Å) were pre-washed with methanol/ethyl acetate (6:4) for 30 minutes. Individual 
channels were loaded with the indicated amount of diacylglycerol standard (Avanti Lipids) or 
vacuolar lipids. Plates were run twice with CH2Cl2/ethyl acetate/acetone (80:16:4) to 40 and 55 
mm then hexanes/ethyl acetate to 68 mm (90:10), 80 mm (95:5), and 90 mm (100:0). Plates 




10 minutes before charring at 145º C for 10 minutes. Imaging of plates was performed using a 
BioRad ChemiDoc™ MP Visualization System (605/50 filter, Green Epi illumination). 
Densitometry values were measured using Image Lab 4.0.1 software. 
GST-Vam7 SNARE complex isolation and bypass fusion  
SNARE complex isolation was performed as described previously using GST-Vam7.23,47,48 
Briefly, 6X fusion reactions were incubated with 85 µg/ml anti-Sec17 IgG to block priming. After 
15 min, 2 µM Gyp1-56 or 2 mM propranolol were added to selected reactions and incubated 
for an additional 5 min before adding 150 nM GST-Vam7. After a total of 90 min, reactions were 
placed on ice and 30 µl aliquots were removed to measure Pho8 activity. The remaining 150 µl 
reactions were sedimented (11,000 g, 10 min, 4C), and the supernatants were discarded 
before extracting vacuoles with solubilization buffer (SB: 20 mM HEPES-KOH, pH 7.4, 100 mM 
NaCl, 2 mM EDTA, 20% glycerol, 0.5% Triton X-100, 1 mM DTT) with protease inhibitors (1 mM 
PMSF, 10 µM Pefabloc-SC, 5 µM pepstatin A, and 1 µM leupeptin). Vacuole pellets were 
overlaid with 100 µl SB and resuspended gently. An additional 100 µl SB was added, gently 
mixed, and incubated on ice for 20 min. Insoluble debris was sedimented (16,000 g, 10 min, 
4C) and 176 µl of supernatants were removed and placed in chilled tubes. Next, 16 µl was 
removed from each reaction as 10% total samples, mixed with 8 µl of 3X SDS loading buffer and 
heated (95C, 5 min). Equilibrated glutathione beads (30 µl) were incubated with the remaining 




min, 4C), and bound material was eluted with 40 µl 1X SDS loading buffer. Protein complexes 
were examined by Western blotting.  
Ca2+ efflux assay  
Vacuole lumen Ca2+ efflux was measured as described.43 Fusion reactions (2X) contained 
20 µg of vacuoles isolated from BJ3505 backgrounds, fusion reaction buffer and the fluorescent 
Ca2+ probe Fluo-4 dextran at 150 nM (Invitrogen). Reaction mixtures were transferred to a black 
96-well plate. ATP regenerating system, or buffer was added and reactions were incubated at 
27C while monitoring Fluo-4 fluorescence (ex=488 nm; em=520 nm). 
Lipid mixing 
Lipid Mixing assays were conducted using rhodamine B DHPE (Rh-PE; Thermo Fisher) as 
described.41 BJ3505 vacuoles (300 µg) were isolated and then incubated in 400 µl of PS buffer 
containing 150 µM Rh-PE (10 min, 4°C, nutating). Next, 800 µl of 15% Ficoll was added and then 
transferred to an 11 x 60 mm pollyalomar ultracentrifuge tube, overlaid with 1.2 ml of 8% and 
4%, and 0.5 ml of PS buffer. Labeled vacuoles were isolated by centrifugation (105,200 X g, 25 
min, 4°C, SW-60 Ti rotor) and recovered from the 0-4% Ficoll interface. Lipid mixing assays (90 
µl) contained 2 µg of labeled vacuoles and 16 µg of unlabeled vacuoles in fusion buffer. 
Reaction mixtures were transferred to a black, half volume 96-well flat-bottom microtiter plate 
on ice. The plate was transferred to a fluorescence plate reader at 27°C to start the reactions. 




em=590 nm) at the onset (F0) and during the reaction (Ft). After 40 min 0.45% (vol/vol) Triton X-
100 was added and the final 10 measurements were averaged to give the value of fluorescence 
after infinite dilution (FTX100). The relative fluorescence change ΔFt/FTX100 = (Ft - F0)/FTX100 - F0 was 
calculated. 
Microscopy  
Vacuole morphology was monitored by incubating yeast with YPD broth containing the vital dye 
FM4-64.89 Cultures were grown to saturation, diluted to ~0.2 OD600 in YPD containing 5 µM 
FM4-64, grown for 1 h in 30C shaker, washed with PBS, and resuspended in dye-free YPD to 
chase the dye for 3 h at 30C. Cells were washed in PBS, mixed with 0.6% agarose, and 
mounted on glass slides for observation. Images were acquired using a Zeiss Axio Observer Z1 
microscope equipped with an X-Cite 120XL light source, Plan Apochromat 63X oil objective (NA 
1.4), and an AxioCam CCD camera.  
Statistical analysis  
Statistical analysis was calculated using one-way ANOVA or two-tailed paired t-test. P 
values of ≤0.05 were considered significant. The half maximal inhibitory concentrations (IC50) 




















Figure 3.1. Dgk1 is localized to the vacuole. (A) Vacuole morphology was examined using wild type, dgk1, pah1, and dgk1 pah1 yeast. Cells were incubated 
with 5 M FM4-64 to label vacuoles. (B) Quantitation of vacuole fragmentation. The number of vacuoles per cell was determined for each strain (n>300 cells per 
strain). Cells with 8 or more vacuoles were combined into one population. (C) Dgk1-GFP expression in wild type and pah1 strains were double labeled with FM4-64 
and used for fluorescence microscopy. (D) Immunoblotting of Dgk1-HA3 distribution in 10 µg samples of whole cell lysates, cytosol, vacuoles, endoplasmic reticulum 
and total membrane fraction using anti-HA antibody. Ypt7 and Sec61 were probed for as a controls for vacuole or endoplasmic reticulum enrichment. (E) Western 
blot analysis. Shown is the vacuolar enrichment of Dgk1 on vacuoles relative to contaminating membranes from the endoplasmic reticulum. Using densitometry, the 
relative amount of vacuolar Dgk1 was measured as a ratio to the amount of Sec61 in the vacuolar preparation and set to 1. The Dgk1/Sec61 ratio was also 








Figure 3.2. DAG vacuolar content. (A) Neutral lipids were extracted from wild type and dgk1 vacuoles and resolved by thin layer chromatography. Lipids were 









Figure 3.3. Dgk1 suppresses vacuole fusion. (A) Fusion reactions were performed using wild type and dgk1 vacuoles. Reactions were incubated at 27C for the 
indicated times and assayed for Pho8 activity. The red trace represents dgk1 fusion when normalized to its own maximum. This reveals the rate of dgk1 vacuole 
fusion versus wild type. (B) The ratio of effector and reporter vacuoles were altered to show early versus late rounds of fusion. To show early rounds of fusion an 
excess of effector vacuoles (5 g PEP4 pho8) were incubated with 1 g of reporter vacuoles (pep4 PHO8). To show late rounds of fusion, an excess of reporter 
vacuoles (4 g pep4 PHO8) were incubated with 2 g of effector vacuoles (PEP4 pho8). (C) Lipid mixing assay were performed with wild type or dgk1 vacuoles. 
Reporter vacuoles (2 g) labeled with Rh-PE were incubated with 16 g of unlabeled vacuoles. Fluorescence (ex=544 nm; em=590 nm) was measured every 60 sec 
for 40 min. Shown is the average lipid mixing at 40 min. (D) Measurement of vacuole diameters after incubation (27C, 90 min). Fusion reactions were treated with 
PS buffer, 12 g/ml anti-Sec18, or 2 mM propranolol (Prop.). Measurements were plotted as a box plot representing median vacuoles with upper and lower quartile 
values. The lines extending from the boxes represent the minimum and maximum vacuoles in the data set. Outliers are displayed as points. (E-F) Fusion assays were 
performed with vacuoles from wild type, dgk1, or dgk1 strains complemented with pDGK1 or pDGK1D177A. (G) Endpoint fusion efficiency was compared between 
wild type, dgk1, pah1, and pah1 dgk1 vacuoles. (H) Analysis of fusion components. Vacuoles were isolated from wild type BJ3505 and RFY17 (BJ3505 dgk1) 
(5 g protein) and immunoblotted with antibodies against the indicated proteins. To examine the effect of deleting DGK1 on Pep4 trafficking, vacuoles were 





Figure 3.4. SNARE complex formation and Ca
2+
 efflux are not affected on dgk1 vacuoles. (A) Anti-Sec17 IgG bypass fusion. Fusion reactions were treated with 
anti-Sec17 IgG to block the priming stage of fusion. Recombinant GST-Vam7 was added at the indicated concentrations to stimulate fusion. (B) SNARE complex 
formation as described in the Materials and Methods section. (C) Quantitation of three GST-Vam7 pulldown assays. Protein band intensities were normalized to wild 
type at 27C without inhibitors. (n=3). (D) Fusion reactions (2X) were prepared with 20 µg of wild type or dgk1 vacuoles in the presence of 150 nM low affinity 
Fluo-4 dextran in the presence or absence of ATP. A subset of reactions was treated with 2 µM Gyp1-46 to inhibit Ypt7 activity and block Ca2+ efflux. Fluo-4 





Figure 3.5. Deletion of DGK1 confers resistance to PA (A) Fusion reactions were performed using wild type or dgk1 vacuoles. Fusion reactions containing wild type 
or dgk1 vacuoles treated with PS buffer, 2 µM GST-FYVE, 20 µM GST-ENTH, 10 µM MBP-FappPH, 20 µM Filipin, 1 µM His6-MTM1 or 1.2 µM SigD. (B-D) Dose 










Figure 3.6. The augmented fusion of dgk1 vacuoles is linked to Ypt7 function. (A) Fusion reactions were performed using wild type or dgk1 vacuoles. 
Individually, reactions were treated with PS buffer (Control), or antibodies against Nyv1 (17 µg/ml), Vam3 (27 µg/ml), Vps33 (5 µg/ml) or Ypt7 (8 µg/ml). (B-D) Dose 
response curves of anti-Ypt7 IgG (B), Gyp1-46 (C), and GDI (D). Reactions containing wild type of dgk1 vacuoles were incubated for 90 min at 27C and tested for 








Figure 3.7. The dgk1 fusion effect is in parallel to the function of Yck3. (A-B) Immunoblotting and quantitation of Yck3 content on vacuoles from wild type and 
dgk1 cells. (C) Immunoblotting of Mon1 release from vacuoles during the fusion reaction. Fusion reactions were incubated for 0, 30, or 60 min after which 
membranes (bound) and supernatants (unbound) were separated by centrifugation (13,000 g, 15 min, 4C). (D) Quantitation of bound Mon1 at the indicated times. 
(E) Fusion reactions containing were treated with indicated concentrations of recombinant His6-Yck3. (F) Fusion of wild type, dgk1, yck3 and dgk1/yck3 





Figure 3.8. Fusion of dgk1 vacuoles and resistance to diC8-PA. (A) Exogenous addition of DAG at the indicated concentrations to fusion reactions containing wild 
type or dgk1 vacuoles. Inset shows the direct comparison of 5 nM DAG and buffer with an equivalent volume of carrier (EtOH).  (B) Lipid mixing using wild type and 
dgk1 vacuoles in the presence of 5 nM DAG or buffer with an equivalent volume of EtOH. (C) Anti-Sec17 IgG bypass fusion reactions using wild type or dgk1 
vacuoles. Individual fusion reactions were treated with recombinant GST-Vam7Q283R to stimulate fusion. Fusion reactions were incubated for 90 min at 27C. Error 






Figure 3.9. Schematic of role of PA and DAG production and modification on vacuole fusion. (A) Wild type fusion (PAH1 DGK1) leads to a reduction of PA by Pah1 
and increase in DAG at the start of the pathway to promote SNARE priming, Ypt7 activation and support fusion. (B) In the absence of Dgk1 there is an accumulation 
of DAG leading to increased Ypt7 activity and augmented fusion. (C) In the absence of Pah1 high PA levels are maintained that sequester Sec18 from SNARE 
complexes and preventing priming. Consequently, Ypt7 activity is blocked and fusion is abrogated. (D) The double deletion of PAH1 and DGK1 does not restore 






Table 3.1. Yeast strains used in this study 
Strain Genotype Source 
BJ3505 MATa pep4::HIS3 prb1-1.6R his3–200 lys2–801 trp1101
 
(gal3) 
ura3–52 gal2 can1 
90
 
DKY6281 MAT pho8::TRP1 leu2–3
 




RFY17 BJ3505, pah1::kanMX6 
19
 
RFY18 DKY6281, pah::kanMX6 
19
 
CHY53 BJ3505, yck3::hphMX4 
46
 
CHY54 DKY6281, yck3::hphMX4 
46
 
RFY60 BJ3505, dgk1::hphMX4 This study 
RFY61 DKY6281, dgk1::hphMX4 This study 
RFY62  RFY17, dgk1:: hphMX4 This study 
RFY63  RFY18, dgk1:: hphMX4 This study 
RFY64 RFY60, pRS416-DGK1 This study 
RFY65 RFY61, pRS416-DGK1 This study 
RFY66 RFY60, pRS416-DGK1
D177A
 This study 
RFY67 RFY61, pRS416-DGK1
D177A
 This study 
RFY68 BJ3505, DGK1::GFP-kanMX6 This study 
RFY69 BJ3505, DGK1::3XHA-kanMX6 This study 
RFY71 RFY68, pah1:: hphMX4 This study 
RFY72 RFY60, yck3:: kanMX6 This study 



















 5'-CGGCTGTAGCGGACCAACTTAGCAAAAATAACGATATTAAGG-3'  
5’-DGK1-GFP/HA 5'-ATCACTTTTTATGAACGCAGTAATCAAAACATTCAAGAAACGGAT CCCCGGGTTAATTAA-
3' 
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CHAPTER 4: PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE NEGATIVELY REGULATES CALCIUM 
TRANSPORT DURING YEAST VACUOLAR FUSION 
ABSTRACT 
During osmotic shock yeast vacuoles undergo fission and release luminal Ca2+ stores. Both 
events require the production of the phosphoinositide PI(3,5)P2 by the PI3P 5-kinase 
Fab1/PIKfyve. Ca2+ is also released during vacuole fusion, however, the role of PI(3,5)P2 remains 
unclear. Here we demonstrate that exogenously added PI(3,5)P2 abolished Ca
2+ efflux during 
fusion. Thus, PI(3,5)P2 has opposing effects on Ca
2+ transport in fission versus fusion. Notably, 
preventing PI(3,5)P2 production with Apilimod increased Ca
2+ efflux, further demonstrating that 
PI(3,5)P2 inhibits fusion-linked Ca
2+ release. We also found that the suppressed Ca2+ release 
depended on the Pmc1 Ca2+ pump. Finally we determined that PI(3,5)P2 enhanced association 
of Pmc1 and Nyv1. Therefore, we now propose that PI(3,5)P2 activates Pmc1 by enhancing 
Pmc1-Nyv1 association leading to reduced extraluminal Ca2+ during fusion, and that the 
turnover of this lipid inactivates Pmc1 leading to the observed fusion-linked Ca2+ efflux.  
INTRODUCTION 
The role of Ca2+ as a regulator of synaptic vesicle fusion with the plasma membrane is well 
understood. Upon plasma membrane depolarization an influx of Ca2+ into the cytoplasm is 
observed which subsequently binds to the C2 domains of synaptotagmin-1. Once bound to Ca2+, 
the synaptotagmin-1 changes conformation and aids in triggering SNARE-mediated fusion 1. 
Ca2+ transport across membranes is also a part of endolysosomal trafficking, yet its exact 




Ca2+ reservoir where it is complexed with inorganic polyphosphate 2. The transport of Ca2+ at 
the vacuole is mediated through the channel Yvc1, the H+/Ca2+ exchanger Vcx1, and the ATP 
driven pump Pmc1 3. 
Although the effectors of Ca2+ remain unidentified, we do have a partial understanding 
of the mechanisms driving the release of Ca2+ during intracellular membrane trafficking. During 
osmotic shock or mechanical stress, the mucolipin transient receptor potential cation channel 
(TRPML) family orthologue Yvc1, transports Ca2+ from the vacuole lumen to the cytosol 4,5. This 
is due in part to the formation of the lipid phosphatidylinositol 3,5-bisphosphate [PI(3,5)P2] by 
the PI3P 5-kinase Fab1/PIKfyve 6 which leads to Ca2+ release through direct activation of Yvc1 7. 
The release of Ca2+ by Yvc1 is also linked to the fission of vacuoles. 
During membrane fusion the release of Ca2+ is triggered by trans-SNARE pairing 8 
through a transporter yet to be identified. Previously it was believed that Ca2+ was necessary for 
vacuolar fusion to proceed past the trans-SNARE pairing stage as the chelator BAPTA potently 
inhibits fusion, albeit at millimolar concentrations 9. However, work by Starai et al. showed that 
this inhibition was through modulation of ionic strength as fusion could be rescued by addition 
of KCl, suggesting Ca2+ is a byproduct of fusion and not necessarily a prerequisite 10. Owing to 
the fact that no specific channel has been implicated in vacuolar fusion associated Ca2+ efflux it 
has been postulated that the release may be due to transient pore opening during the fusion 
process 11. 
An outstanding question is whether Ca2+ release during either vacuolar fission or fusion 




Although yeast contain a group of C2 domain proteins termed tricalbins that are part of the 
extended synaptotagmin family, their function lies in linking the endoplasmic reticulum to the 
plasma membrane and not in vacuole homeostasis 12. That said, there are several possible 
mechanisms by which Ca2+ efflux might contribute to the regulation of vacuole fusion. The 
efflux of Ca2+ is likely to neutralize the electrostatic repulsion of anionic lipids at the site of 
fusion. This neutralization would facilitate the tight apposition of membranes and subsequent 
fusion 13,14. In addition, Ca2+ can also affect the clustering of plasma membrane SNAREs by 
neutralizing negatively charged amino acid side chains 15. 
Other roles for Ca2+ release could be interdependently linked with V-ATPase function. 
Excess Ca2+ inhibits V-ATPase function 16. Conversely, inhibition of V-ATPase activity by deletion 
of components or treatment with Concanamycin A blocks the ability of Vcx1 to detoxify the 
cytoplasm after an increase in Ca2+ 17. Furthermore, Ca2+ transport is driven by a proton motive 
force, as ionophores such as CCCP and Nigericin block Ca2+ uptake 18. The interdependence 
between Ca2+ and H+ transport is further supported by reports showing the direct interaction of 
the V-ATPase and Ca2+ channels 19,20. In homotypic vacuole fusion, blocking the V-ATPase 
subunit Vph1 with antibody completely blocked Ca2+ efflux 21. 
In this study we examined the role of regulatory lipids in the release of Ca2+ during 
homotypic vacuole fusion. We found that PI(3,5)P2 led to inhibition of Ca
2+ release rather than 
its stimulation as seen in vacuole fission. This was complemented with inhibition of the PI3P 5-
kinase Fab1/PIKfyve with the small molecule Apilimod that led to enhanced release of Ca2+. We 
show that the effect of PI(3,5)P2 on Ca




pump Pmc1. Additionally we find that PI(3,5)P2 alters Pmc1-Nyv1 complex formation by 
enhancing their association. Thus, we conclude that the observed Ca2+ efflux during vacuole 
homotypic fusion is caused by inactivation of Ca2+ influx due to reduced Pmc1-Nyv1 association 
rather than a byproduct of transient pore formation or release by a Ca2+ efflux channel. 
RESULTS 
Ca2+ Efflux is negatively regulated by PI(3,5)P2 during fusion 
The release of vacuole luminal Ca2+ stores occurs upon trans-SNARE complex formation in the 
path towards fusion 8. The formation of vacuole SNARE complexes also relies on the assembly 
of membrane microdomains enriched in regulatory lipids that include phosphoinositides such 
as PI3P 22. However, the link between phosphoinositides and Ca2+ transport during fusion has 
remained unclear. By contrast, the dependence of Ca2+ efflux on PI(3,5)P2 during vacuole fission 
under hyperosmotic conditions has been well documented 7. Together, this served as the 
impetus to explore the role of phosphoinositides in fusion-linked Ca2+ transport. 
To address this gap in knowledge, we used isolated vacuoles for in vitro assays of Ca2+ 
flux and fusion. Ca2+ transport was monitored through changes in Fluo-4 fluorescence as 
previously described 23. Vacuoles were incubated under fusion conditions and reactions were 
started by the addition of ATP. As seen before, the addition of ATP triggers the rapid uptake of 
extraluminal Ca2+ from the buffer into the vacuole lumen as shown by the decrease in Fluo-4 
fluorescence (Fig. 1A, black squares). Omission of ATP prevents Ca2+ uptake and fluorescence 
remains stable (Fig. 1A, open squares). Shortly after, and in a SNARE dependent manner, Ca2+ is 




for SNARE-dependent efflux, select reactions were treated with antibody against Sec17 (-
SNAP), a co-chaperone of Sec18 (NSF) that aids in disrupting inactive cis-SNARE complexes to 
initiate the fusion pathway (Fig. 1A, open triangles) 24. 
To test the effects of specific lipids on Ca2+ transport, we treated reactions with 
dioctonyl (diC8) derivatives of PI3P, PI(3,5)P2 and phosphatidic acid (PA). PA was included due 
to its inhibitory effect on Sec18 25, while PI3P was included as a pro-fusion lipid 26–29. To 
examine the effects of exogenous lipid on solely efflux, lipids were added after the completion 
of uptake (t=6 min). After six minutes the control (+ATP) reaction starts the efflux process that 
is linked to the formation of trans-SNARE complexes. Unlike the control we found that reactions 
treated diC8-PI(3,5)P2 (58 µM) completely blocked Ca
2+ efflux in a manner similar to our 
standard negative control -Sec17 IgG. In parallel we found that diC8-PI3P showed a relatively 
minor inhibition, while diC8-PA exhibited no significant change in Ca2+ efflux. Interestingly, 
higher concentrations of diC8-PA showed a profound increase in Ca2+ efflux (Fig. 1B). The effect 
of the elevated Ca2+ release caused by PA remains unknown. However, it should be noted that 
Ca2+ inhibits vacuole fusion at elevated concentrations 30. We also know that PA inhibits fusion 
at two stages. PA first inhibits early in the reaction at the priming phase through sequestering 
Sec18 25. Fusion remains sensitive to PA after priming is complete at a time that coincides with 
the docking stage when SNARE pairing occurs and Ca2+ is released. This suggests that PA-
triggered Ca2+ release might be the second point of fusion inhibition.  
We next sought to determine whether the inhibitory effect of PI(3,5)P2 on Ca
2+ efflux 




at concentrations that completely blocked Ca2+ release (58 M) had little effect on fusion, 
whereas high concentrations (>150 µM) blocked fusion as well as PA (Fig. 1C). PI3P had little 
effect at any of the concentrations tested. Taken together, these data demonstrate that 
PI(3,5)P2 acts as a potent inhibitor of Ca
2+ efflux during vacuolar fusion, which is in stark contrast 
to its role as an inducer of Ca2+ efflux during vacuolar fission. Furthermore, these results show 
that altering the levels of PI(3,5)P2 can uncouple Ca
2+ efflux from vacuole fusion.  
Inhibition of the PI3P 5-Kinase Fab1/PIKFyve leads to enhanced Ca2+ Efflux. 
So far our studies have utilized the addition of exogenous short chain lipids to regulate 
Ca2+ efflux, however it is possible that the observed effects were due to removal of regulatory 
proteins from the membrane by soluble lipids. Thus it is vital to test whether the inhibition of 
native lipid modifying enzymes can induce the same effects. To address this we examined 
whether inhibition of Fab1/PIKfyve by Apilimod would alter Ca2+ efflux 31. We first tested the 
efficacy of isolated vacuoles to convert BODIPY-TMR C6-PI3P to BODIPY-TMR C6-PI(3,5)P2. 
Vacuoles were incubated in the presence of BODIPY-TMR C6-PI3P and treated with either 
vehicle or Apilimod. To enhance PI(3,5)P2 detection, reactions were incubated in the presence 
of 1 mM sodium orthovanadate to block non-specific dephosphorylation. Reactions were 
quenched by the addition of acetone, and phosphoinositides were extracted via Bligh and Dyer 
methods under acidic conditions 32. Extracted lipids were resolved by thin-layer 
chromatography (TLC) to visualize lipid concentrations of individual species via fluorescence. 
Pure BODIPY-TMR lipid standards were used as migration markers. Isolated vacuoles were 




diminished when the reactions were maintained at 27C, suggesting that the Fab1 product has 
a short half-life under these conditions. This is likely due to the PI(3,5)P2 5’-phosphatse activity 
of Fig4 activity (Fig. 2A).We next tested if Apilimod blocked Fab1 activity as it does for PIKfyve. 
Using this agent, we measured a significant reduction in BODIPY-TMR C6-PI(3,5)P2 generation 
indicating Apilimod is able to negatively affect Fab1 activity in yeast (Fig. 2B).  
The effects of Apilimod on Ca2+ efflux were then monitored as in Figure 1, as a control 
for our system we utilized Verapamil, a known inhibitor of Ca2+ transporters. Curiously, when 
vacuoles were treated with Apilimod following Ca2+ influx (t=6), we observed an almost 
instantaneous release of Ca2+ whereas Verapamil had no significant effect on efflux (Fig. 3A-C). 
The rapid Ca2+ release triggered by Apilimod was not due to lysis as fusion was not affected. 
Lysis of vacuoles is known to inhibit the processing of substrates by vacuolar proteases and 
would interfere with the detection of fusion, however Apilimod showed no inhibition of fusion 
(Fig. 3D) 33. As neither inhibition of Ca2+ efflux nor stimulation was able to significantly 
modulate fusion we conclude that Ca2+ efflux can be uncoupled from vacuolar membrane fusion 
through altering the stoichiometry of regulatory lipids. Taken together our data indicates the 
vacuolar levels of PI3P and PI(3,5)P2 potently regulate Ca
2+ efflux during the fusion process. 
Fig4 turnover of PI(3,5)P2 enhances Ca
2+ efflux 
We next examined how Ca2+ transport would be affected through reduction of PI(3,5)P2 
levels via the deletion of FAB1 or its regulator FIG4, a PI(3,5)P2 5-phosphatase that is required 
for Fab1 activity in vivo 34. To see if long-term elimination of Fab1 activity could alter Ca2+ 




assay. We show that Ca2+ efflux is markedly decreased in fab1 vacuoles. In contrast, the rate 
of Ca2+ efflux was enhanced in fig4 vacuoles compared to WT; however, the overall amount of 
efflux remained unchanged (Fig. 4A-B). This may be due to the lack of total inhibition of Fab1 
activity on fig4 vacuoles and was similar to the effects of Apilimod. While we predicted that 
the loss of Fab1 would lead to an enhancement of Ca2+ efflux as seen in fig4 vacuoles, Ca2+ 
efflux was instead severely inhibited in terms of both rate and magnitude. One reason for this 
might be linked to the trafficking defects seen in fab1 cells, which might directly or indirectly 
affect Ca2+ transport. A characteristic sorting defect in fab1 cells is the missorting of 
carboxypeptidase S to the limiting membrane of the vacuole instead of the lumen 35. We have 
also observed the absence of key fusion regulators on isolated fab1 vacuoles (Miner & Fratti, 
unpublished). It is important to note that morphological defects are not seen in the FIG4 
deletion strain, suggesting membrane trafficking is closer to a “wild type” state and may explain 
why Ca2+ efflux events are still observed in comparison to FAB1 deletion 36. 
PI(3,5P)2 acts to regulate Pmc1 during fusion 
To identify the mechanism by which PI(3,5)P2 regulates Ca
2+ release during fusion we 
generated knockouts of the known vacuolar Ca2+ transporters: Pmc1, Vcx1, and Yvc1. As 
reported by Merz and Wickner, deletion of these transporters was unable to abolish the release 
of Ca2+ during fusion 8. In keeping with their findings we found that Ca2+ efflux was close to wild 
type. We also observed a reduction in Ca2+ influx with vacuoles lacking Pmc1 (Fig. 5A-B). We 
next asked if treating these deletion strains with PI(3,5)P2 would inhibit Ca
2+ efflux to the same 
extent as seen with WT vacuoles. In Figure 5 we show that PI(3,5)P2 inhibited Ca




the deletion strains tested except for pmc1. This suggests that Ca2+ transport regulation by 
PI(3,5)P2 occurs through Pmc1. If PI(3,5)P2 is truly acting to trigger Pmc1 activity then its Ca
2+ 
efflux inhibition should be reversible through inhibition of Ca2+ influx by Verapamil. In accord, 
the co-treatment of vacuoles with PI(3,5)P2 and Verapamil restored Ca
2+ efflux (Fig. 5 A-B). To 
understand how Pmc1 may be regulated by PI(3,5)P2 we performed pulldown studies on TAP-
tagged Pmc1 to see if PI(3,5)P2 alters Pmc1 protein interactions. Intriguingly we found 
treatment with PI(35)P2 lead to a drastic increase in Pmc1-Nyv1 association (Fig. 6). Pmc1-Nyv1 
are known to interact during the early stages of fusion and it was proposed that Nyv1 may 
inactivate Pmc1 11. Given our new findings we now propose that Nyv1 actually stimulates Pmc1 
activity during membrane fusion and that PI(3,5)P2 stimulates this association causing 
abolishment of Ca2+ efflux.  
Based on these results we can conclude that PI(3,5)P2 is able to potently regulate Ca
2+ 
transport in a Pmc1 dependent manner through modulation of protein interactions. We also 
conclude that fusion related Ca2+ efflux was not due to enhanced efflux, through a channel or 
transient pores, but was rather a result of reduced Ca2+ influx by Pmc1 and subsequent buildup 
of extraluminal Ca2+.  
DISCUSSION 
The yeast vacuole serves as the primary reservoir for Ca2+ as well as H+, and these ions 
are translocated across the membrane through multiple channels including Pmc1, Yvc1, Vxc1, 
and the V-ATPase. Although the regulatory mechanisms for each of these transporters is not 




specific manner. For instance, PI(3,5)P2 serves as a activator of the Vph1 subunit of the V-
ATPase on the vacuole, while its homolog Stv1 in Golgi localized V-ATPase is controlled by PI4P 
37. PI(3,5)P2 has additionally been shown to regulate Ca
2+ release through Yvc1 during the 
osmotically driven vacuole fission 7. Ca2+ is also released from the vacuole during the fusion 
process; however, the channel(s) involved is uncertain 8,9,21. The exact role of Ca2+ release 
during vacuole fusion or fission remains enigmatic, in contrast to the well-defined role of Ca2+ in 
binding synaptotagmin during synaptic vesicle fusion 38,39. In this study we sought to investigate 
the role vacuole specific regulatory lipids play in Ca2+ transport during the homotypic 
membrane fusion process. 
Our work has identified PI(3,5)P2 as a novel repressor of homotypic vacuole fusion 
associated Ca2+ efflux while having little effect on fusion at the same concentration (58 M). 
This repression appears to be through activation of Pmc1, as efflux was significantly enhanced 
in strains lacking Pmc1 compared to WT when treated with PI(3,5)P2. A potential mechanism for 
this activity is through promotion of Pmc1-Nyv1 complexes as PI(3,5)P2 treatment led to a 
drastic increase in association. Furthermore, it appears that the regulation is immediate, as 
treatment with the Fab1/PIKfyve inhibitor Apilimod led to a rapid release of Ca2+, suggesting 
that PI(3,5)P2 needs to be continually generated to regulate Ca
2+ transport. Another intriguing 
finding was that in contrast to PI(3,5)P2, PA acted to enhance Ca
2+ efflux. This suggests PA may 
act in opposition to PI(3,5)P2 in terms of ion transport, though further work would be required 




One of the most striking findings from our study is the fact that fusion associated Ca2+ 
efflux appears to be through inactivation of Ca2+ influx rather than activation of an efflux 
channel or transient pore opening as has been assumed. A possible explanation for this 
inactivation is decreased association of Nyv1 with Pmc1 following trans-SNARE. It is known that 
PI(3,5)P2 can alter the conformation of Vph1 leading to altered complex formation 
40 therefore 
PI(3,5)P2 is potentially causing similar conformation changes in Pmc1 leading to altered 
association with Nyv1. An alternative explanation is PI(3,5)P2’s effects are mediated through 
Vph1 leading to altered complex formation through interactions with Nyv1. While this may give 
insight into the mechanism behind Ca2+ efflux during the fusion process it does not indicate the 
potential physiological role of this Ca2+ during fusion. Importantly we found that fusion could be 
uncoupled from enhanced extraluminal Ca2+ concentrations though altering the lipid 
stoichiometry.  
Another possible explanation for Ca2+ efflux during fusion is a decrease in PI(3,5)P2 levels 
leading to decreased activity of Pmc1. Consistent with this we did find that PI(3,5)P2 levels were 
drastically reduced after 15 minutes which is coincident with the time frame of Ca2+ release, 
however further work would need to be done to evaluate this possibility. Finally, it is important 
to recognize that in the context of fusion PI(3,5)P2 inhibited Ca
2+ efflux, while this lipid enhances 
efflux during fission. This may indicate that there are additional levels of regulating Pmc1 




Taken together our data indicate that PI(3,5)P2 is able to regulate fusion associated Ca
2+ 
transport through activation of Pmc1. Furthermore, this suggests that the perceived Ca2+ efflux 
is a result of Pmc1 inactivation rather than an enhancement of efflux pathways.  
MATERIALS AND METHODS 
Reagents  
Soluble reagents were dissolved in PIPES-Sorbitol (PS) buffer (20 mM PIPES-KOH, pH 6.8, 
200 mM sorbitol) with 125 mM KCl unless indicated otherwise. Anti-Sec17 IgG (Mayer et al., 
1996), and Pbi2 (Slusarewicz et al., 1997) were prepared as described previously. DiC8-PA (1,2-
dioctanoyl-sn-glycero-3-phosphate) diC8-PI3P (1,2-dioctanoyl-phosphatidylinositol 3-
phosphate), and diC8-PI(3,5)P2 (1,2-dioctanoyl-phosphatidylinositol 3,5-bisphosphate), BODIPY-
TMR C6-PI3P and BODIPY-TMR C6-PI(3,5)P2 were purchased from Echelon Inc. Apilimod, 
Verapamil, and Bafilomycin A1 were from Cayman Chemical and dissolved in DMSO. FCCP 
(Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone) was purchased from Sigma and 
dissolved in DMSO. 
Strains 
FAB1 was deleted by homologous recombination using PCR products amplified using 5’-
FAB1-KO and 3’-FAB1-KO primers with homology flanking the FAB1 coding sequence (Table 1). 
The PCR product was transformed into yeast by standard lithium acetate methods and plated 
on YPD media containing G418 (250 µg/l) to generate BJ3505 fab1::kanMX6 (RFY74). 




products using primers that flanked the specific open reading frames to make RFY74-82 (Table 
2). 
Vacuole Isolation and In-vitro fusion assay 
Vacuoles were isolated as described (Haas et al., 1994). In vitro fusion reactions (30 µl) 
contained 3 µg each of vacuoles from BJ3505 and DKY6281 backgrounds, reaction buffer 20 
mM PIPES-KOH pH 6.8, 200 mM sorbitol, 125 mM KCl, 5 mM MgCl2), ATP regenerating system 
(1 mM ATP, 0.1 mg/ml creatine kinase, 29 mM creatine phosphate), 10 µM CoA, and 283 nM 
Pbi2 (Protease B inhibitor). Fusion reactions were incubated at 27°C for 90 min and Pho8 
activity was measured in 250 mM Tris-HCl pH 8.5, 0.4% Triton X-100, 10 mM MgCl2, and 1 mM 
p-nitrophenyl phosphate. Pho8 activity was inhibited after 5 min by addition of 1 M glycine pH 
11 and fusion units were measured by determining the p-nitrophenolate produced by detecting 
absorbance at 400 nm. 
Calcium Efflux 
Vacuole lumen Ca2+ was measured as described (Sasser et al., 2012). In vitro Ca2+ 
transport reactions (60 µl) contained 20 µg vacuoles from BJ3505 backgrounds, fusion reaction 
buffer, 10 µM CoA, 283 nM Pbi2, and 150 nM of the Ca2+ probe Fluo-4 dextran (Invitrogen). 
Reaction mixtures were loaded into a black, half-volume 96-well flat-bottom plate with 
nonbinding surface (Corning). ATP regenerating system or buffer was added and reactions were 
incubated at 27°C while Fluo-4 fluorescence was monitored. Samples were analyzed using a 
POLARstar Omega fluorescence plate reader (BMG Labtech) with the excitation filter at 485 nm 




system following the initial measurement. The effects of inhibitors on efflux were determined 
by the addition of buffer, inhibitors, or diC8-lipids immediately following Ca2+ influx. Calibration 
was done using buffered Ca2+ standards (Invitrogen).  
PI3P 5-kinase assay and Thin-Layer Chromatography 
Fab1 kinase activity was measured with an assay adapted from the detection of Fig4 and 
Plc1 activity (Jun et al., 2004; Rudge et al., 2004) with some modifications. Kinase reactions (30 
µl) contained 6 µg vacuoles from BJ3505 backgrounds, fusion reaction buffer, ATP regenerating 
system, 10 µM CoA, 283 nM Pbi2, 2 µM BODIPY-TMR C6-PI3P, and 1 mM sodium 
orthovanadate. Reaction mixtures were incubated at 27°C in the presence of PS Buffer, DMSO, 
or Apilimod. Reactions were quenched with acetone (100µL) after incubation. Following 
incubation acidic phospholipids were extracted from all reactions (Sasser et al., 2013). TLC 
plates (Partisil LK6D Silica Gel Plates (60Å), Whatman) were pretreated with 1.2 mM EGTA and 
1% potassium oxalate (w/v) in MeOH/Water (3:2) and then dried at 100°C for 30 min prior to 
use. Dried lipids were resuspended in CHCl3/MeOH (1:1) (40 µl) and 5 ul was spotted on the 
plate. Plates were run in CHCl3/acetone/MeOH/AcOH/Water (46:17:15:14:8). Individual 
channels were loaded with PI3P and PI(3,5)P2 standards (Echelon). Imaging of plates was 
performed using a ChimiDoc MP System (BioRad) and densitometry was determined with 
Image Lab 4.0.1 software.  
TAP-TAG Pulldown 
Vacuoles were isolated from yeast harboring PMC1 fused to a tandem affinity 




some modification. 10% of the extract was removed for input samples. 15X fusion reactions 
(450 μl) were treated with either PS, GDI, or 253µM PI(3,5)P2 and incubated for 5 minutes at 
4°C. Reactions were transferred to a water bath at 27°C  and incubated for 85 minutes. 
Vacuoles were re-isolated by centrifugation (11,000 X g, 10 min, 4ºC), and the supernatants 
decanted before extracting vacuoles with 600µL solubilization buffer (SB) (15 mMNa2HPO4, 10 
mM NaH2PO4-H2O, 1.0% Nonidet P-40 alternative, 150 mM NaCl, and 2 mM EDTA, 1mM PMSF) 
and incubated at 4 °C for 20 min. with nutating. Insoluble debris was sedimented by 
centrifugation (16,000 X g, 10 min, 4ºC), and 540 μl of supernatants were transferred to new 
chilled tubes. Next, 54 µl was removed from each reaction as 10% total samples, mixed with 
SDS loading buffer and heated (95ºC, 5 min). The remaining extracts were incubated with 50 μl 
equilibrated IgG Sepharose 4B beads (GE Healthcare) (12 h, 4ºC, nutating). Beads were 
sedimented (735 X g, 2 min, 4ºC) and washed with 1 ml SB five times, and bound material was 

































Figure 4.1. Regulatory lipids affect Ca2+ transport by isolated vacuoles. (A) Vacuoles were harvested from BJ3505 and 2X fusion reactions containing 150 nM Fluo-4 
dextran. diC8-PI3P, diC8-PA and diC8-PI(3,5)P2 were added at 116 M at the start of the reaction along with ATP (t=0 min). Reactions were incubated at 27C and 
fluorescence was measured every 30 sec for 50 min. Values were normalized to 1.0 and expressed as relative (Rel.) values compared to the untreated control. (B) A 
close-up of the first 6 minutes from panel A. (C) Dose response of diC8 lipids on Ca2+ release normalized to the untreated control reaction. (D) Late addition of diC8 
lipids and Ca2+ release. Reactions were carried out as in panel A, except that diC8 lipids were added after 6 min of incubation with ATP (arrow). (E) Dose response of 
diC8 lipids as in panel C, except that diC8 lipids were added after 6 min of incubation with ATP. (F) Dose response of diC8 lipids on vacuole fusion. Vacuoles from 
BJ3505 and DKY6281 were incubated for 90 min at 27C. The arrow indicates the concentration of lipids that alter Ca2+ transport. (G-H) Ca2+ transport inhibition by 
Verapamil. Vacuoles were treated with DMSO (carrier) or the indicated concentration of Verapamil and Ca2+ transport was determined as shown in panels A and B. 
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Figure 4.2. Vacuoles generate PI(3,5)P2 under fusion conditions and Apilimod acts to block Fab1 activity (A) Vacuoles produce PI(3,5)P2 under fusion conditions. 
Vacuoles were incubated with BODIPY-TMR C6- and 1mM sodium orthovanadate at 27C for the indicated times after which lipids were extracted and resolved by 











































































Figure 4.3. Inhibition of PI(3,5)P2 production by Fab1 inhibits vacuolar Ca
2+
 uptake during fusion (A) Vacuoles were incubated with Apilimod to inhibit Fab1 and 
Ca2+ transport was measured as described above. (B) Quantitation of the time at which Ca2+ is released in the presence of Apilimod, Verapamil and DMSO. (C) 
Quantitation of the effects of Apilimod, Verapamil and DSMO as well as Gyp1-46 on Ca2+ efflux. (D) Dose response curve of the effects of Apilimod on Ca2+ uptake 


















































































































































































Figure 4.4. Deletion of FAB1 or the phosphatase FIG4 alters Ca
2+
 transport during fusion. (A) Ca
2+
 transport assays were performed with WT, fab1 or fig4 
vacuoles. (B) Average of multiple experiments shown in panel A where the relative amounts of Ca2+ released are compared between strains. (C) Average of multiple 
experiments where the relative amounts of Ca2+ released are compared for control reactions performed with fab1 or fig4 vacuoles. Error bars are S.E.M. (n=3). 






































































Figure 4.5. PI(3,5)P2 regulates Ca
2+ transport through Pmc1 during fusion. (A) Ca2+ transport assays were performed with WT, pmc1, yvc1 or vcx1 vacuoles as 
described. After 6 min of incubation, select reactions were treated with DMSO, 116 M PI(3,5)P2, 1mM Verapamil or PI(3,5)P2 combined with Verapamil (arrows). 
(B) Average Ca2+ efflux of multiple experiments as performed in panel A. Error bars are S.E.M. (n=3). Statistical significance is shown for ATP (column 2) versus 
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Figure 4.6. PI(3,5)P2 regulates Pmc1-Nyv1 Association. (A) We monitored the association of Pmc1 with its known binding partner Nyv1 utilizing TAP-Pmc1 vacuoles. 
Vacuoles were incubated at 27°C or 4°C for 90 minutes in the presence of PS buffer, GDI, or PI(3,5)P2. After incubation, reactions were centrifuged to isolate the 
































Table 4.1. Yeast strains used in this study 
Strain Genotype Source 
BJ3505 MATa pep4::HIS3 prb1-1.6R his3–200 lys2–801 trp1101 
(gal3) ura3–52 gal2 can1 
(Jones et al., 1982) 
DKY6281 MAT pho8::TRP1 leu2–3 leu 2–112 ura3–52 his3-200 
trp1-901 lys2–801 
(Haas et al., 1994) 
RFY74 BJ3505, fab1::kanMX6 This study 
RFY76  BJ3505, fig4::hphMX4 This study 
RFY78  BJ3505, pmc1::hphMX4 This study 
RFY80  BJ3505, vcx1::hphMX4 This study 
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CHAPTER 5: GENERAL DISCUSSION 
In this study, I have examined the role of various glycerophospholipids in vacuole 
membrane fusion regulation. It is clear that lipids play crucial regulatory roles in membrane 
fusion with a large diversity of mechanism. This study has demonstrated three distinct modes 
of regulation: recruitment of fusion machinery through direct binding interactions, reduction of 
force requirements through bilayer disruption, and modulation of fusion machinery complex 
formation through direct binding interactions. In chapter II I examined the role of an 
intramolecular binding interaction which modulates the affinity of the soluble SNARE Vam7 for 
PI3P. In Chapter III I examined the role of DAG and PA balance on membrane fusion and 
specifically how increased levels of DAG promote membrane fusion. Finally in Chapter IV I 
investigated the ability of PI(3,5)P2 to modulate ion transport during membrane fusion through 
modulation of fusion protein complexes. Additionally, this study supports the concept that 
regulatory lipids are spatiotemporally controlled as a means to regulate the various stages of 
membrane fusion though follow up work will be required to further elucidate these 
mechanisms.  
Intramolecular interactions Allow a Catch and Release Mechanism of Vam7 Lipid Binding 
In Chapter II I identified a role for the Mid-Domain (MD) of the soluble SNARE Vam7 in 
PI3P binding. Owing to the presence of a polybasic region (PBR) which are commonly found in 
lipid binding motifs 1,2, we initially hypothesized that the MD enhanced Vam7’s recruitment to 
the vacuole through PI3P interactions.  The role of the PBR was determined by mutating the 




promoting membrane fusion as shown by the ability to restore vacuolar morphology defects 
found in vam7 strains, it proved to be less efficient than WT Vam7 as shown by in vitro 
studies. A detailed examination of the in vitro fusion process demonstrated that Vam7-6Ala had 
no defects in vacuolar association yet appeared to be deficient in forming fusogenic protein-
protein interactions. While the decreased protein-protein interactions were expected, we 
would have predicted this to be the result of decreased membrane association. The lack of 
defect in vacuolar association suggested our initial hypothesis was incorrect and that the PBR 
did not promote lipid affinity, and in fact inhibits membrane binding as overall vacuole 
association should be an aggregate of membrane and protein binding interactions. As predicted 
we found Vam7-6Ala bound to liposomes bearing PI3P with a higher affinity than WT Vam7 
indicating the PBR acts to reduce lipid affinity. 
Taken together it appears Vam7 utilizes a catch and release mechanism at the vacuole 
to enable fusogenic complex formation through transient PI3P binding. In our proposed model, 
Vam7 is initially recruited by interaction of the PX domain with PI3P. Once localized to the 
vacuolar membrane, specifically the vertex ring where PI3P and the fusion machinery are 
enriched, Vam7 is released allowing it to form proper interactions with the tethering machinery 
and cognate SNAREs via the PX domain and SNARE domain respectively. We propose that the 
initial binding event of Vam7 to PI3P triggers the PBR to inhibit the affinity of the PX domain for 
PI3P and therefore enables release. The PBR of Vam7 may alter the PX domains affinity through 
one of two distinct mechanisms. The PBR may act to competitively bind PI3P and therefore 
inhibit PX domain association. This mechanism seems unlikely however as Vam7’s ability to 




The most likely mode of action therefore is Vam7 regulating affinity to PI3P through 
intramolecular binding of the PBR to the PX domain. In this model PI3P binding causes a 
conformation change allowing the PBR to bind and regulate the PX domain. In support of this 
we have identified an acidic patch on the surface of the PX domain which may act as the PBR’s 
interaction site. Additionally we have determined by dynamic light scattering experiments that 
Vam7 predominately forms dimers whereas Vam7-6Ala only formed monomers, suggesting the 
PBR interacts with Vam7. Further work will need to be done to verify the exact interaction site; 
however, it appears evident that Vam7 requires release from PI3P to properly promote fusion.   
Diacylglycerol Promotes Fusion by Reducing Force Requirements 
In chapter III I evaluated the effect of an in vivo increase in DAG levels. DAG has long 
been established as a fusogenic lipid owing to the fact that DAG can promote liposome fusion 3. 
While in vivo models of reduced DAG have been studied such as loss of Plc1 4, in vivo models of 
elevated DAG levels in vacuolar membrane fusion have not been examined. We determined 
that loss of the DAG kinase, Dgk1, led to elevated levels of DAG at the vacuole and an 
approximately 40% increase in membrane fusion. A detailed look at the stages of fusion 
indicated DAG enhances fusion post hemifusion. Post-hemifusion enhancement suggests DAG 
may reduce the force requirements necessary for pore formation. A reduction in the force 
requirements necessary to promote membrane fusion can be assessed by the ability of a 
mutant form of Vam7, Vam7Q283R, to promote fusion.  Typically Vam7Q283R is unable to stimulate 
membrane fusion due to improper SNARE pairing 5, however this block can be overcome by 




consequently reduces the force required to fuse membranes. We found that enhanced levels of 
in vivo DAG allowed Vam7Q283R to promote fusion reinforcing the concept that elevated DAG 
reduces the force requirements of membrane fusion. Finally, when exogenous DAG was added 
to WT vacuoles only long chain was able to enhance fusion indicating the biophysical properties 
of DAG are necessary for fusion promotion. 
One of the complications of this study is the fact that loss of Dgk1 should not only 
increase DAG levels, but cause an equivalent decrease in PA thought this was not confirmed. PA 
has been established as a negative regulator of vacuolar fusion 6 and therefore it remains 
possible that some of the effects seen were due to decreased levels of PA. This may explain the 
discrepancy between exogenously added long chain DAG and in vivo increases. Specifically 
elevated levels of DAG in vivo showed no significant effect on the hemifusion stage of 
membrane fusion whereas a significant increase in hemifusion was observed with exogenous 
DAG. It’s possible that loss of PA had an adverse effect on the hemifusion transition and thus 
the effects of elevated DAG levels was unable to be observed. It will be of interest to examine 
alternative in vivo models of PA reduction such as deletion of the yeast PLD Spo14 to more 
clearly define the effects of PA reduction vs DAG elevation. Additionally while the overall 
effects of exogenous DAG addition and our Dgk1 deletion were consistent, it’s possible that 
some of the effects seen in the knockout were due non-vacuolar Dgk1 activity. Finally this 
model does not clearly establish whether Dgk1 is inhibitory to fusion by modulation of overall 
DAG/PA balance or whether it plays a regulatory role during precise steps of the fusion cycle. In 
order to gain a clearer understanding of Dgk1 roles in fusion it will be necessary to utilize acute 




PI(3,5)P2 Acts as a Molecular Switch Between Fusion and Fission 
In Chapter IV I examined the effects of sub-inhibitory concentrations of the lipid 
PI(3,5)P2 in membrane fusion assays and determined that PI(3,5)P2 can act as an inhibitor of 
Ca2+ efflux. The vacuole serves as the main storage compartment of Ca2+ in the yeast cell. 
During vacuolar membrane fusion and fission Ca2+ is effluxed, however the exact role of these 
efflux events has not been well established7,8. During membrane fission Ca2+ efflux is caused by 
PI(3,5)P2 generation and subsequent binding to the vacuolar Ca
2+ efflux channel Yvc18. Based on 
this knowledge, we presumed PI(3,5)P2 would act to stimulate Ca
2+ efflux during membrane 
fusion through activation of Yvc1, intriguingly however the opposite was observed and efflux 
was inhibited. As no other Ca2+ export channels are known on the vacuole, we looked at 
whether it was possible for PI(3,5)P2 to inhibit Yvc1 during membrane fusion or stimulate one of 
the two known Ca2+ influx channels, the ATPase Pmc1 or the H+/Ca2+ antiporter Vcx1 9. Vacuoles 
lacking Pmc1 were resistant to PI(3,5)P2 induced inhibition of Ca
2+ efflux indicating that 
PI(3,5)P2 activates Ca
2+ influx through Pmc1 causing a lack of efflux. Additionally loss of Yvc1 did 
not abolish Ca2+ efflux during membrane fusion. Taken together we now believe Ca2+ efflux 
during fusion is in fact an inhibition of Ca2+ influx rather than activity of an efflux pump. 
A large question remaining in the field is whether or not Ca2+ efflux is required during 
membrane fusion. Ca2+ has been associated with trans-SNARE pairing 7 however no direct 
mechanism has been elucidated. Further work indicated Ca2+ removal by chelation with BAPTA 
was permissible as long as buffer ionic strength was maintained 10. Our work clearly 




PI(35)P2 had minimal effect on fusion but fully inhibited Ca
2+ efflux. Not only do we show Ca2+ 
efflux is not required, but additionally it is a distinct event from trans-SNARE pairing. Full 
inhibition of membrane fusion by PI(3,5)P2 has minimal effect on trans-SNARE pairing 
suggesting its effects on Ca2+ are independent of trans-SNARE complex formation (miner 
unpublished).  In follow up studies we also show that Ca2+ efflux can be triggered in a fusion 
independent process through inhibition of Ca2+ influx by the inhibitor Verapamil showing that 
both events are independent(miner unpublished). We propose that post trans-SNARE pairing 
events disrupt Pmc1-Nyv1 interactions 11 leading to inactivation of Pmc1 driven Ca2+ influx. 
Specifically, we believe that trans-Vo interactions 
12 lead to interactions with Nyv1 which 
disrupts Nyv1-Pmc1 interactions (miner unpublished). In this proposed model we place 
PI(3,5)P2 as a molecular switch which can modulate the conformation of Vph1 to disrupt 
fusogenic Vph1-Nyv1 interactions. Inhibition of trans-V0 interactions leads to continued 
activation of Pmc1 Ca2+ influx and at high enough doses cause inhibition of membrane fusion 
with minimal effect on trans-SNARE formation.  
General Conclusions 
The research presented in this dissertation highlights the diverse array of regulation 
controlled by lipids and the equally diverse mechanisms utilized to achieve that regulation. We 
have shown that lipids are not only involved in recruitment of various factors to the appropriate 
membrane, but play roles in modulation of the biophysical properties of membranes and 
appear to function as molecular switches regulating cellular events. Specifically this work has 




to localize Vam7 to the site of membrane fusion where it can be released. It’s also possible that 
more complex regulation may occur where our proposed intramolecular release mechanism 
can be inhibited allowing PI3P to sequester Vam7 until membrane fusion is necessary similar to 
the role of PA in Sec18 regulation 6. We have also shown that DAG is necessary in vivo as a 
means to reduce the force requirements of membrane fusion and that Dgk1 acts to regulate 
membrane fusion through modulation of DAG and PA levels. Finally we identify PI(3,5)P2 as a 
potent inhibitor of Ca2+ efflux during the membrane fusion process. Importantly PI(3,5)P2 was 
able to abolish Ca2+ efflux while not disrupting membrane fusion clearly showing Ca2+ efflux is 
not required for in-vitro membrane fusion. While these studies have given us further insight 
into the ability of lipids to regulate membrane fusion there remains many unanswered 
questions. This work will hopefully serve as a foundation to answer these questions which 
should provide crucial mechanistic details of the membrane fusion process.  
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